<SEC-DOCUMENT>0001193125-20-150104.txt : 20200522
<SEC-HEADER>0001193125-20-150104.hdr.sgml : 20200522
<ACCEPTANCE-DATETIME>20200522161543
ACCESSION NUMBER:		0001193125-20-150104
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20200521
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Material Modifications to Rights of Security Holders
ITEM INFORMATION:		Changes in Control of Registrant
ITEM INFORMATION:		Submission of Matters to a Vote of Security Holders
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20200522
DATE AS OF CHANGE:		20200522

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CONMED CORP
		CENTRAL INDEX KEY:			0000816956
		STANDARD INDUSTRIAL CLASSIFICATION:	ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
		IRS NUMBER:				160977505
		STATE OF INCORPORATION:			NY
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39218
		FILM NUMBER:		20906053

	BUSINESS ADDRESS:	
		STREET 1:		525 FRENCH ROAD
		CITY:			UTICA
		STATE:			NY
		ZIP:			13502
		BUSINESS PHONE:		315-624-3208

	MAIL ADDRESS:	
		STREET 1:		525 FRENCH ROAD
		CITY:			UTICA
		STATE:			NY
		ZIP:			13502
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d193269d8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8" ?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:us-types="http://fasb.org/us-types/2019-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:cnmd="http://conmed.com/20200521" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>Form 8-K</title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
   <body>
 <div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey_duration_2020-05-21_to_2020-05-21" name="dei:EntityCentralIndexKey" contextRef="duration_2020-05-21_to_2020-05-21">0000816956</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_AmendmentFlag_duration_2020-05-21_to_2020-05-21" name="dei:AmendmentFlag" contextRef="duration_2020-05-21_to_2020-05-21">false</ix:nonNumeric> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2020-05-21_to_2020-05-21">false</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xlink:type="simple" xlink:href="cnmd-20200521.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef> </ix:references> <ix:resources> <xbrli:context id="duration_2020-05-21_to_2020-05-21"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000816956</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2020-05-21</xbrli:startDate> <xbrli:endDate>2020-05-21</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="font-size:10pt;width:8.5in;margin:0 auto"> <div style="text-align:center"> <p style="line-height:0.5pt;border-bottom:0.50px solid #000000;width:100%;margin-top:0pt;margin-bottom:0pt">&#160;</p></div> <div style="text-align:center"> <p style="line-height:3pt;border-bottom:0.50px solid #000000;width:100%;margin-top:0pt;margin-bottom:2pt">&#160;</p></div> <p style="margin-bottom:0px;margin-top:4pt"></p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:18pt;margin-bottom:0pt;margin-top:0pt">UNITED STATES</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:18pt;margin-bottom:0pt;margin-top:0pt">SECURITIES AND EXCHANGE COMMISSION</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:12pt;margin-bottom:0pt;margin-top:0pt">Washington, D.C. 20549</p> <div style="text-align:center"> <p style="line-height:6pt;margin-left:auto;border-bottom:1px solid #000000;width:21.05%;margin-right:auto;margin-top:12pt;margin-bottom:0px">&#160;</p></div> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:18pt;margin-bottom:0px;margin-top:12pt">FORM <span style="white-space:nowrap"><ix:nonNumeric name="dei:DocumentType" contextRef="duration_2020-05-21_to_2020-05-21">8-K</ix:nonNumeric> </span></p> <div style="text-align:center"> <p style="line-height:6pt;margin-left:auto;border-bottom:1px solid #000000;width:21.05%;margin-right:auto;margin-top:12pt;margin-bottom:0px">&#160;</p></div> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:12pt;margin-bottom:0px;margin-top:12pt">CURRENT REPORT</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:12pt;margin-bottom:0pt;margin-top:0pt">Pursuant to Section 13 or 15(d)</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:12pt;margin-bottom:0pt;margin-top:0pt">of The Securities Exchange Act of 1934</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:12pt;margin-bottom:0px;margin-top:12pt">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2020-05-21_to_2020-05-21" format="ixt:datemonthdayyearen">May 21, 2020</ix:nonNumeric></p> <div style="text-align:center"> <p style="line-height:6pt;margin-left:auto;border-bottom:1px solid #000000;width:21.05%;margin-right:auto;margin-top:12pt;margin-bottom:0px">&#160;</p></div> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:24pt;margin-bottom:0px;margin-top:12pt"><ix:nonNumeric contextRef="duration_2020-05-21_to_2020-05-21" name="dei:EntityRegistrantName">CONMED CORPORATION</ix:nonNumeric></p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt">(Exact name of registrant as specified in its charter)</p> <div style="text-align:center"> <p style="line-height:6pt;margin-left:auto;border-bottom:1px solid #000000;width:21.05%;margin-right:auto;margin-top:12pt;margin-bottom:0px">&#160;</p></div>
<table cellspacing="0" cellpadding="0" border="0" style="font-size:8pt;border-collapse:separate;border-spacing:0;width:100%;margin-bottom:0px;margin-top:12pt;margin-left:auto;margin-right:auto">
<tr>
<td style="width:34%;"></td>
<td></td>
<td style="width:33%;"></td>
<td style="width:1%;"></td>
<td style="width:33%;"></td></tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:top;padding:0;"><p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2020-05-21_to_2020-05-21" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric></p></td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"><p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2020-05-21_to_2020-05-21">001-39218</ix:nonNumeric></p></td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"><p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt"> <span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2020-05-21_to_2020-05-21">16-0977505</ix:nonNumeric> </span></p></td></tr>
<tr style="page-break-inside:avoid;font-size:8pt;">
<td style="vertical-align:top;padding:0;"><p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">(State or other jurisdiction</p><p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">of incorporation)</p></td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"><p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">(Commission</p><p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">File Number)</p></td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"><p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">(IRS. Employer</p><p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">Identification No.)</p></td></tr> </table> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0px;margin-top:12pt"><ix:nonNumeric contextRef="duration_2020-05-21_to_2020-05-21" name="dei:EntityAddressAddressLine1">525 French Road</ix:nonNumeric></p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt"><ix:nonNumeric contextRef="duration_2020-05-21_to_2020-05-21" name="dei:EntityAddressCityOrTown">Utica</ix:nonNumeric>, <ix:nonNumeric contextRef="duration_2020-05-21_to_2020-05-21" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen">New York</ix:nonNumeric> <ix:nonNumeric contextRef="duration_2020-05-21_to_2020-05-21" name="dei:EntityAddressPostalZipCode">13502</ix:nonNumeric></p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">(Address of principal executive offices, including zip code)</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0px;margin-top:12pt"><ix:nonNumeric contextRef="duration_2020-05-21_to_2020-05-21" name="dei:CityAreaCode">(315)</ix:nonNumeric> <span style="white-space:nowrap"><ix:nonNumeric contextRef="duration_2020-05-21_to_2020-05-21" name="dei:LocalPhoneNumber">797-8375</ix:nonNumeric> </span></p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">(Registrant&#8217;s telephone number, including area code)</p> <div style="text-align:center"> <p style="line-height:6pt;margin-left:auto;border-bottom:1px solid #000000;width:21.05%;margin-right:auto;margin-top:12pt;margin-bottom:0px">&#160;</p></div> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0px;margin-top:12pt">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions (<span style="text-decoration:underline">see</span> General Instruction A.2 below):</p> <p style="margin-bottom:0px;margin-top:6pt"></p>
<table cellspacing="0" cellpadding="0" border="0" style="font-family:Times New Roman;border-collapse:collapse;text-align:left;width:100%;font-size:10pt;margin-bottom:0pt;margin-top:0pt;border:0;">
<tr style="page-break-inside:avoid;">
<td style="width:4%;vertical-align:top;white-space:nowrap;"> <span style="font-family:Times New Roman;font-weight:normal"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2020-05-21_to_2020-05-21" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span></td>
<td style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</td></tr> </table> <p style="margin-bottom:0px;margin-top:6pt"></p>
<table cellspacing="0" cellpadding="0" border="0" style="font-family:Times New Roman;border-collapse:collapse;text-align:left;width:100%;font-size:10pt;margin-bottom:0pt;margin-top:0pt;border:0;">
<tr style="page-break-inside:avoid;">
<td style="width:4%;vertical-align:top;white-space:nowrap;"> <span style="font-family:Times New Roman;font-weight:normal"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2020-05-21_to_2020-05-21" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span></td>
<td style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12) </span></td></tr> </table> <p style="margin-bottom:0px;margin-top:6pt"></p>
<table cellspacing="0" cellpadding="0" border="0" style="font-family:Times New Roman;border-collapse:collapse;text-align:left;width:100%;font-size:10pt;margin-bottom:0pt;margin-top:0pt;border:0;">
<tr style="page-break-inside:avoid;">
<td style="width:4%;vertical-align:top;white-space:nowrap;"> <span style="font-family:Times New Roman;font-weight:normal"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2020-05-21_to_2020-05-21" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span></td>
<td style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt;"> <span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b)) </span></td></tr> </table> <p style="margin-bottom:0px;margin-top:6pt"></p>
<table cellspacing="0" cellpadding="0" border="0" style="font-family:Times New Roman;border-collapse:collapse;text-align:left;width:100%;font-size:10pt;margin-bottom:0pt;margin-top:0pt;border:0;">
<tr style="page-break-inside:avoid;">
<td style="width:4%;vertical-align:top;white-space:nowrap;"> <span style="font-family:Times New Roman;font-weight:normal"><ix:nonNumeric contextRef="duration_2020-05-21_to_2020-05-21" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span></td>
<td style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt;"> <span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c)) </span></td></tr> </table> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0px;margin-top:12pt">Securities registered pursuant to Section 12(b) of the Act:</p>
<table cellspacing="0" cellpadding="0" border="0" style="font-size:8pt;border-collapse:separate;border-spacing:0;width:100%;margin-bottom:0px;margin-top:12pt;margin-left:auto;margin-right:auto">
<tr>
<td style="width:34%;"></td>
<td></td>
<td style="width:33%;"></td>
<td style="width:1%;"></td>
<td style="width:33%;"></td></tr>
<tr style="page-break-inside:avoid;font-size:8pt;">
<td style="border-bottom:1pt solid #000000;white-space:nowrap;vertical-align:bottom;"><p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">Title of each class</p></td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="border-bottom:1pt solid #000000;vertical-align:bottom;"><p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">Trading</p><p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">Symbol</p></td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="border-bottom:1pt solid #000000;vertical-align:bottom;"><p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">Name of each exchange</p><p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">on which registered</p></td></tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:top;padding:0;"><p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt"><ix:nonNumeric contextRef="duration_2020-05-21_to_2020-05-21" name="dei:Security12bTitle">Common Stock, $0.01 par value</ix:nonNumeric></p></td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"><p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt"><ix:nonNumeric contextRef="duration_2020-05-21_to_2020-05-21" name="dei:TradingSymbol">CNMD</ix:nonNumeric></p></td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"><p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt"><ix:nonNumeric contextRef="duration_2020-05-21_to_2020-05-21" name="dei:SecurityExchangeName">NYSE</ix:nonNumeric></p></td></tr> </table> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0px;margin-top:12pt">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 (&#167;<span style="white-space:nowrap">240.12b-2</span> of this chapter).</p> <p style="font-family:Times New Roman;text-align:right;font-size:10pt;margin-bottom:0px;margin-top:12pt">Emerging growth company&#160;&#160;<span style="font-family:Times New Roman;font-weight:normal"><ix:nonNumeric contextRef="duration_2020-05-21_to_2020-05-21" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span></p> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0px;margin-top:12pt">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#160;&#160;<span style="font-family:Times New Roman;font-weight:normal">&#9744;</span></p> <p style="margin-bottom:0px;margin-top:10pt"></p> <div style="text-align:center"> <p style="line-height:0.5pt;border-bottom:0.50px solid #000000;width:100%;margin-top:0pt;margin-bottom:0pt">&#160;</p></div> <div style="text-align:center"> <p style="line-height:3pt;border-bottom:0.50px solid #000000;width:100%;margin-top:0pt;margin-bottom:2pt">&#160;</p></div> <div></div> <p style="margin-top:1em;margin-bottom:0em"></p></div> <p style='page-break-before:always'></p> <hr style="color:#999999;height:3px;width:100%" /> <div style="font-size:10pt;width:8.5in;margin:0 auto">
<table cellspacing="0" cellpadding="0" border="0" style="font-family:Times New Roman;font-weight:bold;border-collapse:collapse;text-align:left;width:100%;font-size:10pt;margin-bottom:0pt;margin-top:0pt;border:0;">
<tr style="page-break-inside:avoid;">
<td style="width:10%;vertical-align:top;white-space:nowrap;">Item&#160;1.01</td>
<td style="font-family:Times New Roman;font-weight:bold;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">Entry into a Material Definitive Agreement.</td></tr></table> <p style="font-family:Times New Roman;text-align:left;text-indent:4%;font-size:10pt;margin-bottom:0px;margin-top:6pt">On May 22, 2020 (the &#8220;Effective Date&#8221;), CONMED Corporation, a New York corporation (&#8220;CONMED New York&#8221; and, prior to the Reincorporation, the &#8220;Company&#8221;), changed its state of incorporation from the State of New York to the State of Delaware (the &#8220;Reincorporation&#8221;) by merging with and into its wholly-owned subsidiary CONMED Corporation, a Delaware corporation (&#8220;CONMED Delaware&#8221; and, following the Reincorporation, the &#8220;Company&#8221;) pursuant to the terms of the Agreement and Plan of Merger, dated May&#160;21, 2020, by and between the Company and Newco (the &#8220;Merger Agreement&#8221;). The Reincorporation and the Merger Agreement were approved by the Board of Directors of CONMED New York. As further described under Item 5.07 of this Current Report on Form <span style="white-space:nowrap">8-K</span> (this &#8220;Current Report&#8221;), the Reincorporation, including the adoption of the Merger Agreement, was approved by the affirmative vote of the holders at least <span style="white-space:nowrap">two-thirds</span> of CONMED New York&#8217;s outstanding shares of common stock entitled to vote at the annual meeting of the Company&#8217;s shareholders held on May&#160;21, 2020 (the &#8220;Annual Meeting&#8221;).</p> <p style="font-family:Times New Roman;text-align:left;text-indent:4%;font-size:10pt;margin-bottom:0px;margin-top:12pt">On the Effective Date, pursuant to the terms of the Merger Agreement:</p> <p style="margin-bottom:0px;margin-top:6pt"></p>
<table cellspacing="0" cellpadding="0" border="0" style="font-family:Times New Roman;border-collapse:collapse;text-align:left;width:100%;font-size:10pt;margin-bottom:0pt;margin-top:0pt;border:0;">
<tr style="page-break-inside:avoid;">
<td style="width:9%;text-align:left;">&#160;</td>
<td style="width:3%;vertical-align:top;">&#8226;</td>
<td style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">The Company merged with and into CONMED Delaware, with CONMED Delaware being the surviving entity, and CONMED New York ceasing to exist as a separate entity;</td></tr></table> <p style="margin-bottom:0px;margin-top:6pt"></p>
<table cellspacing="0" cellpadding="0" border="0" style="font-family:Times New Roman;border-collapse:collapse;text-align:left;width:100%;font-size:10pt;margin-bottom:0pt;margin-top:0pt;border:0;">
<tr style="page-break-inside:avoid;">
<td style="width:9%;text-align:left;">&#160;</td>
<td style="width:3%;vertical-align:top;">&#8226;</td>
<td style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">The shareholders of CONMED New York became the shareholders of CONMED Delaware;</td></tr></table> <p style="margin-bottom:0px;margin-top:6pt"></p>
<table cellspacing="0" cellpadding="0" border="0" style="font-family:Times New Roman;border-collapse:collapse;text-align:left;width:100%;font-size:10pt;margin-bottom:0pt;margin-top:0pt;border:0;">
<tr style="page-break-inside:avoid;">
<td style="width:9%;text-align:left;">&#160;</td>
<td style="width:3%;vertical-align:top;">&#8226;</td>
<td style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">Each outstanding share of CONMED New York&#8217;s common stock, par value $0.01 per share, automatically converted <span style="white-space:nowrap">pro-rata</span> on a <span style="white-space:nowrap">one-to-one</span> basis into shares of the common stock of CONMED Delaware, par value $0.01 per share;</td></tr></table> <p style="margin-bottom:0px;margin-top:6pt"></p>
<table cellspacing="0" cellpadding="0" border="0" style="font-family:Times New Roman;border-collapse:collapse;text-align:left;width:100%;font-size:10pt;margin-bottom:0pt;margin-top:0pt;border:0;">
<tr style="page-break-inside:avoid;">
<td style="width:9%;text-align:left;">&#160;</td>
<td style="width:3%;vertical-align:top;">&#8226;</td>
<td style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">Each outstanding option to purchase shares of CONMED New York&#8217;s common stock converted into an option to acquire an equal number of shares of CONMED Delaware, with no change in the exercise price or other terms or provisions of the option;</td></tr></table> <p style="margin-bottom:0px;margin-top:6pt"></p>
<table cellspacing="0" cellpadding="0" border="0" style="font-family:Times New Roman;border-collapse:collapse;text-align:left;width:100%;font-size:10pt;margin-bottom:0pt;margin-top:0pt;border:0;">
<tr style="page-break-inside:avoid;">
<td style="width:9%;text-align:left;">&#160;</td>
<td style="width:3%;vertical-align:top;">&#8226;</td>
<td style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">Each other equity award relating to CONMED New York&#8217;s common stock was deemed to be an equity award for the same number of shares of CONMED Delaware&#8217;s common stock, with no change in the terms or provisions of the equity award;</td></tr></table> <p style="margin-bottom:0px;margin-top:6pt"></p>
<table cellspacing="0" cellpadding="0" border="0" style="font-family:Times New Roman;border-collapse:collapse;text-align:left;width:100%;font-size:10pt;margin-bottom:0pt;margin-top:0pt;border:0;">
<tr style="page-break-inside:avoid;">
<td style="width:9%;text-align:left;">&#160;</td>
<td style="width:3%;vertical-align:top;">&#8226;</td>
<td style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">CONMED Delaware assumed all of the assets, liabilities, rights, privileges and powers of CONMED New York;</td></tr></table> <p style="margin-bottom:0px;margin-top:6pt"></p>
<table cellspacing="0" cellpadding="0" border="0" style="font-family:Times New Roman;border-collapse:collapse;text-align:left;width:100%;font-size:10pt;margin-bottom:0pt;margin-top:0pt;border:0;">
<tr style="page-break-inside:avoid;">
<td style="width:9%;text-align:left;">&#160;</td>
<td style="width:3%;vertical-align:top;">&#8226;</td>
<td style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">CONMED Delaware is governed by the General Corporation Law of the State of Delaware (the &#8220;DGCL&#8221;) and, as discussed in Item 5.01 of this Current Report, by the Certificate of Incorporation (the &#8220;Delaware Charter&#8221;) and the <span style="white-space:nowrap">By-laws</span> (the &#8220;Delaware <span style="white-space:nowrap">By-laws&#8221;)</span> of CONMED Delaware; and</td></tr></table> <p style="margin-bottom:0px;margin-top:6pt"></p>
<table cellspacing="0" cellpadding="0" border="0" style="font-family:Times New Roman;border-collapse:collapse;text-align:left;width:100%;font-size:10pt;margin-bottom:0pt;margin-top:0pt;border:0;">
<tr style="page-break-inside:avoid;">
<td style="width:9%;text-align:left;">&#160;</td>
<td style="width:3%;vertical-align:top;">&#8226;</td>
<td style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">The officers and directors of CONMED New York became the officers and directors of CONMED Delaware.</td></tr></table> <p style="font-family:Times New Roman;text-align:left;text-indent:4%;font-size:10pt;margin-bottom:0px;margin-top:12pt">The Reincorporation changed the legal domicile of the Company, but did not result in any change in the name, business, management, fiscal year, accounting, location of the principal executive offices, assets or liabilities of the Company. The Company will continue to operate under the name &#8220;CONMED Corporation&#8221; and its common stock will continue to be listed on the New York Stock Exchange under the same ticker symbol &#8220;CNMD.&#8221; Shareholders are not required to exchange their existing stock certificates in connection with the Reincorporation.</p> <p style="font-family:Times New Roman;text-align:left;text-indent:4%;font-size:10pt;margin-bottom:0px;margin-top:12pt">Additionally, as a result of the Reincorporation and pursuant to Rule <span style="white-space:nowrap">12g-3(a)</span> under the Securities and Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), CONMED Delaware is the successor issuer to CONMED New York, and CONMED Delaware&#8217;s common stock is deemed registered under Section&#160;12(b) of the Exchange Act.</p> <p style="font-family:Times New Roman;text-align:left;text-indent:4%;font-size:10pt;margin-bottom:0px;margin-top:12pt">The foregoing description of the Reincorporation and the Merger Agreement does not purport to be complete and is subject to and qualified in its entirety by the full text of the Merger Agreement, a copy of which is attached hereto as Exhibit 2.1 and incorporated herein by reference. A more detailed description of the Merger Agreement and the effects of the Reincorporation is set forth in Proposals 4, 5 and 6 of the Company&#8217;s definitive proxy statement, filed with the Securities and Exchange Commission on April&#160;10, 2020, as supplemented on May&#160;11, 2020 (the &#8220;2020 Proxy Statement&#8221;), which description is incorporated herein by reference. In addition, a description of CONMED Delaware&#8217;s common stock is attached hereto as Exhibit 4.1 and incorporated herein by reference. The information set forth in Item 5.01 of this Current Report on Form <span style="white-space:nowrap">8-K</span> is also incorporated herein by reference.</p> <div></div> <p style="margin-top:1em;margin-bottom:0em"></p></div> <p style='page-break-before:always'></p> <hr style="color:#999999;height:3px;width:100%" /> <div style="font-size:10pt;width:8.5in;margin:0 auto">
<table cellspacing="0" cellpadding="0" border="0" style="font-family:Times New Roman;font-weight:bold;border-collapse:collapse;text-align:left;width:100%;font-size:10pt;margin-bottom:0pt;margin-top:0pt;border:0;">
<tr style="page-break-inside:avoid;">
<td style="width:10%;vertical-align:top;white-space:nowrap;">Item&#160;3.03</td>
<td style="font-family:Times New Roman;font-weight:bold;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">Material Modification to Rights of Security Holders.</td></tr></table> <p style="font-family:Times New Roman;text-align:left;text-indent:4%;font-size:10pt;margin-bottom:0px;margin-top:6pt">The information set forth in Item 1.01 and Item 5.01 of this Current Report on Form <span style="white-space:nowrap">8-K</span> is incorporated herein by reference. In addition, a description of CONMED Delaware&#8217;s common stock is attached hereto as Exhibit 4.1 and incorporated herein by reference.</p> <p style="margin-bottom:0px;margin-top:18pt"></p>
<table cellspacing="0" cellpadding="0" border="0" style="font-family:Times New Roman;font-weight:bold;border-collapse:collapse;text-align:left;width:100%;font-size:10pt;margin-bottom:0pt;margin-top:0pt;border:0;">
<tr style="page-break-inside:avoid;">
<td style="width:10%;vertical-align:top;white-space:nowrap;">Item&#160;5.01</td>
<td style="font-family:Times New Roman;font-weight:bold;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">Amendment to Articles of Incorporation or Bylaws.</td></tr></table> <p style="font-family:Times New Roman;text-align:left;text-indent:4%;font-size:10pt;margin-bottom:0px;margin-top:6pt">As a result of the Reincorporation, the rights of the shareholders of the Company are now governed by the DGCL and by the Delaware Charter and the Delaware <span style="white-space:nowrap">By-laws</span> (together, the &#8220;Delaware Governing Documents&#8221;). Additionally, as disclosed under Item 5.07 of this Current Report, at the Annual Meeting the Company&#8217;s shareholders also approved the inclusion in the Delaware Charter of a director exculpation provision and certain procedural provisions with respect to shareholder action by written consent.</p> <p style="font-family:Times New Roman;text-align:left;text-indent:4%;font-size:10pt;margin-bottom:0px;margin-top:12pt">Copies of the Delaware Charter and the Delaware <span style="white-space:nowrap">By-laws</span> are attached hereto as Exhibits 3.1 and 3.2, respectively, and incorporated herein by reference. A detailed description of the changes in the rights of the Company&#8217;s shareholders as a result of the Reincorporation and the adoption of the Delaware Governing Documents is set forth in Proposals 4, 5 and 6 of the Company&#8217;s 2020 Proxy Statement, which description is incorporated herein by reference. The information set forth in Item 1.01 of this Current Report on Form <span style="white-space:nowrap">8-K</span> is also incorporated herein by reference.</p> <p style="margin-bottom:0px;margin-top:18pt"></p>
<table cellspacing="0" cellpadding="0" border="0" style="font-family:Times New Roman;font-weight:bold;border-collapse:collapse;text-align:left;width:100%;font-size:10pt;margin-bottom:0pt;margin-top:0pt;border:0;">
<tr style="page-break-inside:avoid;">
<td style="width:10%;vertical-align:top;white-space:nowrap;">Item&#160;5.07</td>
<td style="font-family:Times New Roman;font-weight:bold;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">Submission of Matters to a Vote of Security Holders.</td></tr></table> <p style="font-family:Times New Roman;text-align:left;text-indent:4%;font-size:10pt;margin-bottom:0px;margin-top:6pt">The Annual Meeting was held on May&#160;21, 2020. Holders of CONMED New York common stock were entitled to elect ten directors. On all matters which came before the Annual Meeting, holders of CONMED New York common stock were entitled to one vote for each share held. Proxies for 26,509,552 of the 28,527,662 shares of CONMED New York common stock entitled to vote were received in connection with the Annual Meeting.</p> <p style="font-family:Times New Roman;text-align:left;text-indent:4%;font-size:10pt;margin-bottom:0px;margin-top:12pt">The following table sets forth the names of the ten persons elected at the Annual Meeting to serve as directors until the first annual meeting of shareholders following the end of the Company&#8217;s fiscal year ending December&#160;31, 2020 and the number of votes cast for, against or withheld with respect to each person.</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:left;font-size:10pt;margin-bottom:0px;margin-top:18pt">Election of Directors</p>
<table cellspacing="0" cellpadding="0" border="0" style="font-size:10pt;border-collapse:separate;border-spacing:0;width:100%;margin-bottom:0px;margin-top:12pt;margin-left:auto;margin-right:auto">
<tr>
<td style="width:94%;"></td>
<td style="width:1%;"></td>
<td></td>
<td></td>
<td></td>
<td style="width:1%;"></td>
<td></td>
<td></td>
<td></td>
<td style="width:1%;"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="border-bottom:1pt solid #000000;white-space:nowrap;vertical-align:bottom;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt"> <span style="font-weight:Bold;font-style:normal">Director</span></p></td>
<td style="vertical-align:bottom;">&#160;</td>
<td colspan="2" style="border-bottom:1pt solid #000000;vertical-align:bottom;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt"> <span style="font-weight:Bold;font-style:normal">&#160;&#160;&#160;&#160;Votes&#160;Received</span>&#160;&#160;&#160;&#160;</p></td>
<td style="vertical-align:bottom;font-weight:bold;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:bottom;">&#160;</td>
<td colspan="2" style="border-bottom:1pt solid #000000;vertical-align:bottom;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt"> <span style="font-weight:Bold;font-style:normal">&#160;&#160;&#160;&#160;Votes&#160;Withheld</span>&#160;&#160;&#160;&#160;</p></td>
<td style="vertical-align:bottom;font-weight:bold;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:bottom;">&#160;</td>
<td colspan="2" style="border-bottom:1pt solid #000000;white-space:nowrap;vertical-align:bottom;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt"> <span style="font-weight:Bold;font-style:normal">&#160;&#160;&#160;&#160;Broker&#160;Non-Votes</span>&#160;&#160;&#160;&#160;</p></td>
<td style="white-space:nowrap;vertical-align:bottom;font-weight:bold;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td></tr>
<tr style="font-size:1pt;">
<td style="height:13px;">&#160;</td>
<td style="height:13px;">&#160;</td>
<td style="height:13px;">&#160;</td>
<td style="height:13px;">&#160;</td>
<td style="height:13px;">&#160;</td>
<td style="height:13px;">&#160;</td>
<td style="height:13px;">&#160;</td>
<td style="height:13px;">&#160;</td>
<td style="height:13px;">&#160;</td>
<td style="height:13px;">&#160;</td>
<td style="height:13px;">&#160;</td>
<td style="height:13px;">&#160;</td>
<td style="height:13px;">&#160;</td></tr>
<tr style="background-color:#cceeff;page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;margin-left:1.00em;text-align:left;text-indent:-1.00em;font-size:10pt;margin-bottom:0pt;margin-top:0pt">David Bronson</p></td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:bottom;text-align:center"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">24,547,232</p></td>
<td style="vertical-align:bottom;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:bottom;text-align:center"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">587,872</p></td>
<td style="vertical-align:bottom;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:bottom;text-align:center"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">1,374,448</p></td>
<td style="vertical-align:bottom;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;margin-left:1.00em;text-align:left;text-indent:-1.00em;font-size:10pt;margin-bottom:0pt;margin-top:0pt">Brian Concannon</p></td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:bottom;text-align:center"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">24,911,663</p></td>
<td style="vertical-align:bottom;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:bottom;text-align:center"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">223,441</p></td>
<td style="vertical-align:bottom;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:bottom;text-align:center"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">1,374,448</p></td>
<td style="vertical-align:bottom;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td></tr>
<tr style="background-color:#cceeff;page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;margin-left:1.00em;text-align:left;text-indent:-1.00em;font-size:10pt;margin-bottom:0pt;margin-top:0pt">LaVerne Council</p></td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:bottom;text-align:center"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">24,985,886</p></td>
<td style="vertical-align:bottom;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:bottom;text-align:center"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">149,218</p></td>
<td style="vertical-align:bottom;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:bottom;text-align:center"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">1,374,448</p></td>
<td style="vertical-align:bottom;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;margin-left:1.00em;text-align:left;text-indent:-1.00em;font-size:10pt;margin-bottom:0pt;margin-top:0pt">Charles Farkas</p></td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:bottom;text-align:center"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">24,906,003</p></td>
<td style="vertical-align:bottom;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:bottom;text-align:center"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">229,101</p></td>
<td style="vertical-align:bottom;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:bottom;text-align:center"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">1,374,448</p></td>
<td style="vertical-align:bottom;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td></tr>
<tr style="background-color:#cceeff;page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;margin-left:1.00em;text-align:left;text-indent:-1.00em;font-size:10pt;margin-bottom:0pt;margin-top:0pt">Martha Goldberg Aronson</p></td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:bottom;text-align:center"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">24,816,151</p></td>
<td style="vertical-align:bottom;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:bottom;text-align:center"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">318,953</p></td>
<td style="vertical-align:bottom;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:bottom;text-align:center"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">1,374,448</p></td>
<td style="vertical-align:bottom;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;margin-left:1.00em;text-align:left;text-indent:-1.00em;font-size:10pt;margin-bottom:0pt;margin-top:0pt">Curt R. Hartman</p></td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:bottom;text-align:center"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">23,929,638</p></td>
<td style="vertical-align:bottom;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:bottom;text-align:center"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">1,205,466</p></td>
<td style="vertical-align:bottom;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:bottom;text-align:center"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">1,374,448</p></td>
<td style="vertical-align:bottom;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td></tr>
<tr style="background-color:#cceeff;page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;margin-left:1.00em;text-align:left;text-indent:-1.00em;font-size:10pt;margin-bottom:0pt;margin-top:0pt">Jerome J. Lande</p></td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:bottom;text-align:center"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">24,905,739</p></td>
<td style="vertical-align:bottom;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:bottom;text-align:center"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">229,365</p></td>
<td style="vertical-align:bottom;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:bottom;text-align:center"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">1,374,448</p></td>
<td style="vertical-align:bottom;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;margin-left:1.00em;text-align:left;text-indent:-1.00em;font-size:10pt;margin-bottom:0pt;margin-top:0pt">Barb Schwarzentraub</p></td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:bottom;text-align:center"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">24,984,921</p></td>
<td style="vertical-align:bottom;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:bottom;text-align:center"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">150,183</p></td>
<td style="vertical-align:bottom;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:bottom;text-align:center"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">1,374,448</p></td>
<td style="vertical-align:bottom;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td></tr>
<tr style="background-color:#cceeff;page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;margin-left:1.00em;text-align:left;text-indent:-1.00em;font-size:10pt;margin-bottom:0pt;margin-top:0pt">Mark E. Tryniski</p></td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:bottom;text-align:center"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">24,631,728</p></td>
<td style="vertical-align:bottom;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:bottom;text-align:center"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">503,376</p></td>
<td style="vertical-align:bottom;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:bottom;text-align:center"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">1,374,448</p></td>
<td style="vertical-align:bottom;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;margin-left:1.00em;text-align:left;text-indent:-1.00em;font-size:10pt;margin-bottom:0pt;margin-top:0pt">Dr. John Workman</p></td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:bottom;text-align:center"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">24,602,616</p></td>
<td style="vertical-align:bottom;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:bottom;text-align:center"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">532,488</p></td>
<td style="vertical-align:bottom;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:bottom;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:bottom;text-align:center"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">1,374,448</p></td>
<td style="vertical-align:bottom;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td></tr></table> <div></div> <p style="margin-top:1em;margin-bottom:0em"></p></div> <p style='page-break-before:always'></p> <hr style="color:#999999;height:3px;width:100%" /> <div style="font-size:10pt;width:8.5in;margin:0 auto"> <p style="font-family:Times New Roman;font-weight:bold;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt">Management Proposals</p>
<table cellspacing="0" cellpadding="0" border="0" style="font-size:10pt;border-collapse:separate;border-spacing:0;width:100%;margin-bottom:0px;margin-top:12pt;margin-left:auto;margin-right:auto">
<tr>
<td style="width:56%;"></td>
<td style="width:4%;"></td>
<td></td>
<td></td>
<td></td>
<td style="width:4%;"></td>
<td></td>
<td></td>
<td></td>
<td style="width:4%;"></td>
<td></td>
<td></td>
<td></td>
<td style="width:4%;"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:bottom;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt"></p></td>
<td style="vertical-align:bottom;">&#160;</td>
<td colspan="2" style="border-bottom:1pt solid #000000;vertical-align:bottom;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt"> <span style="font-weight:Bold;font-style:normal">For</span></p></td>
<td style="vertical-align:bottom;font-weight:bold;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:bottom;">&#160;</td>
<td colspan="2" style="border-bottom:1pt solid #000000;vertical-align:bottom;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt">&#160;&#160;&#160;&#160;<span style="font-weight:Bold;font-style:normal">Against</span>&#160;&#160;&#160;&#160;</p></td>
<td style="vertical-align:bottom;font-weight:bold;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:bottom;">&#160;</td>
<td colspan="2" style="border-bottom:1pt solid #000000;vertical-align:bottom;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt"> <span style="font-weight:Bold;font-style:normal">&#160;&#160;&#160;&#160;Abstain</span>&#160;&#160;&#160;&#160;</p></td>
<td style="vertical-align:bottom;font-weight:bold;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:bottom;">&#160;</td>
<td colspan="2" style="border-bottom:1pt solid #000000;white-space:nowrap;vertical-align:bottom;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt"> <span style="font-weight:Bold;font-style:normal">Broker&#160;Non-Votes</span></p></td>
<td style="white-space:nowrap;vertical-align:bottom;font-weight:bold;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td></tr>
<tr style="font-size:1pt;">
<td style="height:13px;">&#160;</td>
<td style="height:13px;">&#160;</td>
<td style="height:13px;">&#160;</td>
<td style="height:13px;">&#160;</td>
<td style="height:13px;">&#160;</td>
<td style="height:13px;">&#160;</td>
<td style="height:13px;">&#160;</td>
<td style="height:13px;">&#160;</td>
<td style="height:13px;">&#160;</td>
<td style="height:13px;">&#160;</td>
<td style="height:13px;">&#160;</td>
<td style="height:13px;">&#160;</td>
<td style="height:13px;">&#160;</td>
<td style="height:13px;">&#160;</td>
<td style="height:13px;">&#160;</td>
<td style="height:13px;">&#160;</td>
<td style="height:13px;">&#160;</td></tr>
<tr style="background-color:#cceeff;page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt">Ratification of the appointment of PricewaterhouseCoopers LLP as independent registered public accounting firm for the Company for the fiscal year ending December 31, 2020</p></td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;padding:0;text-align:center"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">25,612,446</p></td>
<td style="vertical-align:top;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;padding:0;text-align:center"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">845,913</p></td>
<td style="vertical-align:top;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;padding:0;text-align:center"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">51,193</p></td>
<td style="vertical-align:top;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;padding:0;text-align:center"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">1,374,448</p></td>
<td style="vertical-align:top;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;margin-left:1.00em;text-align:left;text-indent:-1.00em;font-size:10pt;margin-bottom:0pt;margin-top:0pt"></p></td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;padding:0;text-align:center"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt"></p></td>
<td style="vertical-align:top;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;padding:0;text-align:center"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt"></p></td>
<td style="vertical-align:top;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;padding:0;text-align:center"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt"></p></td>
<td style="vertical-align:top;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;padding:0;text-align:center"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt"></p></td>
<td style="vertical-align:top;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td></tr>
<tr style="background-color:#cceeff;page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt">Approve Advisory Vote on Named Executive Officer Compensation</p></td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;padding:0;text-align:center"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">23,975,870</p></td>
<td style="vertical-align:top;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;padding:0;text-align:center"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">1,105,189</p></td>
<td style="vertical-align:top;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;padding:0;text-align:center"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">54,045</p></td>
<td style="vertical-align:top;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;padding:0;text-align:center"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">1,374,448</p></td>
<td style="vertical-align:top;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;margin-left:1.00em;text-align:left;text-indent:-1.00em;font-size:10pt;margin-bottom:0pt;margin-top:0pt"></p></td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;padding:0;text-align:center"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt"></p></td>
<td style="vertical-align:top;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;padding:0;text-align:center"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt"></p></td>
<td style="vertical-align:top;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;padding:0;text-align:center"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt"></p></td>
<td style="vertical-align:top;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;padding:0;text-align:center"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt"></p></td>
<td style="vertical-align:top;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td></tr>
<tr style="background-color:#cceeff;page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt">Approve the Reincorporation from New York to Delaware, Including Adoption of the Merger Agreement and Approval of the Delaware Charter and Delaware By-laws</p></td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;padding:0;text-align:center"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">24,872,367</p></td>
<td style="vertical-align:top;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;padding:0;text-align:center"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">212,048</p></td>
<td style="vertical-align:top;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;padding:0;text-align:center"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">50,689</p></td>
<td style="vertical-align:top;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;padding:0;text-align:center"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">1,374,448</p></td>
<td style="vertical-align:top;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;margin-left:1.00em;text-align:left;text-indent:-1.00em;font-size:10pt;margin-bottom:0pt;margin-top:0pt"></p></td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;padding:0;text-align:center"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt"></p></td>
<td style="vertical-align:top;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;padding:0;text-align:center"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt"></p></td>
<td style="vertical-align:top;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;padding:0;text-align:center"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt"></p></td>
<td style="vertical-align:top;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;padding:0;text-align:center"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt"></p></td>
<td style="vertical-align:top;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td></tr>
<tr style="background-color:#cceeff;page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt">Approve Delaware Written Consent Procedural Provision</p></td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;padding:0;text-align:center"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">24,860,045</p></td>
<td style="vertical-align:top;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;padding:0;text-align:center"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">224,677</p></td>
<td style="vertical-align:top;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;padding:0;text-align:center"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">50,382</p></td>
<td style="vertical-align:top;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;padding:0;text-align:center"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">1,374,448</p></td>
<td style="vertical-align:top;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;margin-left:1.00em;text-align:left;text-indent:-1.00em;font-size:10pt;margin-bottom:0pt;margin-top:0pt"></p></td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;padding:0;text-align:center"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt"></p></td>
<td style="vertical-align:top;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;padding:0;text-align:center"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt"></p></td>
<td style="vertical-align:top;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;padding:0;text-align:center"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt"></p></td>
<td style="vertical-align:top;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;padding:0;text-align:center"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt"></p></td>
<td style="vertical-align:top;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td></tr>
<tr style="background-color:#cceeff;page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;margin-left:1.00em;text-align:left;text-indent:-1.00em;font-size:10pt;margin-bottom:0pt;margin-top:0pt">Approve Delaware Director Exculpation Provision</p></td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;padding:0;text-align:center"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">24,857,513</p></td>
<td style="vertical-align:top;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;padding:0;text-align:center"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">175,940</p></td>
<td style="vertical-align:top;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;padding:0;text-align:center"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">101,651</p></td>
<td style="vertical-align:top;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;padding:0;text-align:center"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">1,374,448</p></td>
<td style="vertical-align:top;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;margin-left:1.00em;text-align:left;text-indent:-1.00em;font-size:10pt;margin-bottom:0pt;margin-top:0pt"></p></td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;padding:0;text-align:center"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt"></p></td>
<td style="vertical-align:top;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;padding:0;text-align:center"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt"></p></td>
<td style="vertical-align:top;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;padding:0;text-align:center"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt"></p></td>
<td style="vertical-align:top;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;padding:0;text-align:center"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt"></p></td>
<td style="vertical-align:top;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td></tr>
<tr style="background-color:#cceeff;page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;margin-left:1.00em;text-align:left;text-indent:-1.00em;font-size:10pt;margin-bottom:0pt;margin-top:0pt">Approve Non-Employee Director Equity Plan</p></td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;padding:0;text-align:center"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">19,082,033</p></td>
<td style="vertical-align:top;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;padding:0;text-align:center"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">6,001,427</p></td>
<td style="vertical-align:top;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;padding:0;text-align:center"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">51,644</p></td>
<td style="vertical-align:top;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;padding:0;text-align:center"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">1,374,448</p></td>
<td style="vertical-align:top;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;margin-left:1.00em;text-align:left;text-indent:-1.00em;font-size:10pt;margin-bottom:0pt;margin-top:0pt"></p></td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;padding:0;text-align:center"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt"></p></td>
<td style="vertical-align:top;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;padding:0;text-align:center"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt"></p></td>
<td style="vertical-align:top;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;padding:0;text-align:center"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt"></p></td>
<td style="vertical-align:top;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;padding:0;text-align:center"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt"></p></td>
<td style="vertical-align:top;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td></tr>
<tr style="background-color:#cceeff;page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;margin-left:1.00em;text-align:left;text-indent:-1.00em;font-size:10pt;margin-bottom:0pt;margin-top:0pt">Approve Employee Stock Purchase Plan</p></td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;padding:0;text-align:center"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">24,728,352</p></td>
<td style="vertical-align:top;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;padding:0;text-align:center"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">339,298</p></td>
<td style="vertical-align:top;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;padding:0;text-align:center"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">67,454</p></td>
<td style="vertical-align:top;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;padding:0;text-align:center"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">1,374,448</p></td>
<td style="vertical-align:top;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td></tr></table> <p style="margin-bottom:0px;margin-top:18pt"></p>
<table cellspacing="0" cellpadding="0" border="0" style="font-family:Times New Roman;font-weight:bold;border-collapse:collapse;text-align:left;width:100%;font-size:10pt;margin-bottom:0pt;margin-top:0pt;border:0;">
<tr style="page-break-inside:avoid;">
<td style="width:10%;vertical-align:top;white-space:nowrap;">Item&#160;8.01</td>
<td style="font-family:Times New Roman;font-weight:bold;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">Other Events.</td></tr></table> <p style="font-family:Times New Roman;text-align:left;text-indent:4%;font-size:10pt;margin-bottom:0px;margin-top:6pt">On May&#160;21, 2020, CONMED Corporation announced it will be paying a quarterly cash dividend of $0.20 per share on July&#160;6, 2020 to all shareholders of record as of June&#160;15, 2020.</p> <p style="margin-bottom:0px;margin-top:18pt"></p>
<table cellspacing="0" cellpadding="0" border="0" style="font-family:Times New Roman;font-weight:bold;border-collapse:collapse;text-align:left;width:100%;font-size:10pt;margin-bottom:0pt;margin-top:0pt;border:0;">
<tr style="page-break-inside:avoid;">
<td style="width:10%;vertical-align:top;white-space:nowrap;">Item&#160;9.01</td>
<td style="font-family:Times New Roman;font-weight:bold;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">Financial Statements and Exhibits.</td></tr></table> <p style="font-family:Times New Roman;font-weight:bold;text-align:left;font-size:10pt;margin-bottom:0px;margin-top:6pt">(d) Exhibits</p>
<table cellspacing="0" cellpadding="0" border="0" style="font-size:10pt;border-collapse:separate;border-spacing:0;width:92%;margin-bottom:0px;margin-top:12pt;margin-left:auto;margin-right:auto">
<tr>
<td></td>
<td></td>
<td></td>
<td style="width:6%;"></td>
<td style="width:92%;"></td></tr>
<tr style="page-break-inside:avoid;font-size:8pt;">
<td colspan="2" style="white-space:nowrap;vertical-align:bottom;text-align:center;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt;border-bottom:1pt solid #000000;display:inline-block">Exhibit<br />No.</p></td>
<td style="white-space:nowrap;vertical-align:bottom;font-weight:bold;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;display:inline-block;">&#160;</td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:center;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt;border-bottom:1pt solid #000000;display:inline-block">Description</p></td></tr>
<tr style="font-size:1pt;">
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td></tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="white-space:nowrap;vertical-align:top;padding:0;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="white-space:nowrap;vertical-align:top;padding:0;text-align:center"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">2.1</p></td>
<td style="white-space:nowrap;vertical-align:top;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;margin-left:0.00em;text-align:left;text-indent:0.00em;font-size:10pt;margin-bottom:0pt;margin-top:0pt"> <a href="d193269dex21.htm">Agreement and Plan of Merger, dated May&#160;21, 2020, by and between CONMED Corporation, a New York corporation, and CONMED Corporation, a Delaware corporation. </a></p></td></tr>
<tr style="font-size:1pt;">
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td></tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="white-space:nowrap;vertical-align:top;padding:0;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="white-space:nowrap;vertical-align:top;padding:0;text-align:center"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">3.1</p></td>
<td style="white-space:nowrap;vertical-align:top;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;margin-left:0.00em;text-align:left;text-indent:0.00em;font-size:10pt;margin-bottom:0pt;margin-top:0pt"> <a href="d193269dex31.htm">Certificate of Incorporation of CONMED Corporation, a Delaware corporation. </a></p></td></tr>
<tr style="font-size:1pt;">
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td></tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="white-space:nowrap;vertical-align:top;padding:0;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="white-space:nowrap;vertical-align:top;padding:0;text-align:center"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">3.2</p></td>
<td style="white-space:nowrap;vertical-align:top;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;margin-left:0.00em;text-align:left;text-indent:0.00em;font-size:10pt;margin-bottom:0pt;margin-top:0pt"> <a href="d193269dex32.htm">By-laws of CONMED Corporation, a Delaware corporation. </a></p></td></tr>
<tr style="font-size:1pt;">
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td></tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="white-space:nowrap;vertical-align:top;padding:0;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="white-space:nowrap;vertical-align:top;padding:0;text-align:center"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">4.1</p></td>
<td style="white-space:nowrap;vertical-align:top;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;margin-left:0.00em;text-align:left;text-indent:0.00em;font-size:10pt;margin-bottom:0pt;margin-top:0pt"> <a href="d193269dex41.htm">Description of the Common Stock of CONMED Corporation, a Delaware corporation. </a></p></td></tr>
<tr style="font-size:1pt;">
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td></tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="white-space:nowrap;vertical-align:top;padding:0;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="white-space:nowrap;vertical-align:top;padding:0;text-align:center"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">104</p></td>
<td style="white-space:nowrap;vertical-align:top;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;margin-left:0.00em;text-align:left;text-indent:0.00em;font-size:10pt;margin-bottom:0pt;margin-top:0pt">Cover Page Interactive Data File (embedded within the Inline XBRL document).</p></td></tr></table> <div></div> <p style="margin-top:1em;margin-bottom:0em"></p></div> <p style='page-break-before:always'></p> <hr style="color:#999999;height:3px;width:100%" /> <div style="font-size:10pt;width:8.5in;margin:0 auto"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt">Signature</p> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0px;margin-top:12pt">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</p> <div style="float:right;width:100%">
<table cellspacing="0" cellpadding="0" border="0" style="font-size:10pt;border-collapse:separate;border-spacing:0;width:40%;margin-bottom:0px;margin-top:12pt;margin-left:auto;margin-right:0px">
<tr>
<td style="width:13%;"></td>
<td style="width:1%;"></td>
<td style="width:86%;"></td></tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td colspan="3" style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt">CONMED CORPORATION</p></td></tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td colspan="3" style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt">(Registrant)</p></td></tr>
<tr style="font-size:1pt;">
<td style="height:16px;">&#160;</td>
<td style="height:16px;">&#160;</td>
<td style="height:16px;">&#160;</td></tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt">By:</p></td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;text-align:left;margin-bottom:1pt;font-size:10pt;margin-top:0pt;border-bottom:1px solid #000000">/s/ Daniel S. Jonas</p></td></tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt">Name:</p></td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt">Daniel S. Jonas, Esq.</p></td></tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt">Title:</p></td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt">Executive Vice President, General Counsel&#160;&amp; Secretary</p></td></tr></table></div> <div style="clear:both"></div> <p style="font-family:Times New Roman;margin-left:0%;text-align:left;text-indent:0%;font-size:10pt;margin-bottom:0px;margin-top:12pt">Date: May 22, 2020</p> <div></div> <p style="margin-top:1em;margin-bottom:0em"></p></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-2.1
<SEQUENCE>2
<FILENAME>d193269dex21.htm
<DESCRIPTION>EX-2.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-2.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 2.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AGREEMENT AND PLAN OF MERGER </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">THIS AGREEMENT AND PLAN OF MERGER (this &#147;<U>Merger Agreement</U>&#148;), dated as of May 21, 2020, is by and between CONMED Corporation,
a New York corporation (&#147;<U>Parent</U>&#148;), and CONMED Corporation, a Delaware corporation (&#147;<U>Subsidiary</U>&#148;), pursuant to Article 9 of the Business Corporation Law of the State of New York (the &#147;<U>NYBCL</U>&#148;) and
Subchapter IX of the Delaware General Corporation Law (the &#147;<U>DGCL</U>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">WHEREAS, Parent is a corporation duly organized and
in good standing under the laws of the State of New York; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">WHEREAS, Parent was originally formed under the name Concor Enterprises, Inc.;
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">WHEREAS, Subsidiary is a corporation duly organized and in good standing under the laws of the State of Delaware; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">WHEREAS, Subsidiary is newly formed for the purpose of effecting the transactions contemplated hereby and does not currently hold any
property or have any tax attributes; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">WHEREAS, Parent is authorized to issue (a) 100,000,000 shares of common stock, par value $0.01 per
share (&#147;<U>Parent Common Stock</U>&#148;), of which 28,535,629 shares are issued and outstanding as of the date hereof (which number of outstanding shares is subject to change prior to the Effective Time (as defined below) in connection with
Parent&#146;s repurchase or issuance of shares of Parent Common Stock), and (b) 500,000 shares of preferred stock, par value $0.01 per share, of which none are issued and outstanding as of the date hereof; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">WHEREAS, Subsidiary is authorized to issue 100,000,000 shares of common stock, par value $0.01 per share, of which 100 shares are issued and
outstanding as of the date hereof; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">WHEREAS, Parent currently holds all of the issued and outstanding shares of common stock of
Subsidiary; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">WHEREAS, the respective Boards of Directors of Parent and Subsidiary have determined that it is advisable and in the best
interests of such corporations and their shareholders and stockholder, respectively, for Parent to merge with and into Subsidiary, for the purpose of changing the Parent&#146;s state of incorporation from the State of New York to the State of
Delaware; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">WHEREAS, the parties intend, by executing this Merger Agreement, to adopt a plan of reorganization within the meaning of
Section&nbsp;368 of the Internal Revenue Code of 1986, as amended (the &#147;<U>Code</U>&#148;), and to cause the merger described herein to qualify as a reorganization under the provisions of Section&nbsp;368(a)(1)(F) of the Code; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Board of Directors of Parent has directed that this Merger Agreement be submitted to a vote of Parent&#146;s shareholders for
approval in accordance with the NYBCL and the DGCL. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">NOW, THEREFORE, in consideration of the premises, mutual agreements and covenants
set forth herein, the parties hereto agree as follows: </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">ARTICLE 1.&nbsp;&nbsp;&nbsp;&nbsp;<U>The Merger</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;Upon the terms and subject to the conditions set forth in this Merger Agreement, at the Effective Time, Parent
shall be merged with and into Subsidiary (the &#147;<U>Merger</U>&#148;), and the separate existence of Parent shall cease and Subsidiary shall be the entity surviving the Merger (hereinafter referred to as the &#147;<U>Surviving Entity</U>&#148;),
which shall continue to exist under, and be governed by, the laws of the State of Delaware. The Merger shall have the effects specified in the DGCL, including Section&nbsp;259 of Subchapter IX of Title 8 of the DGCL, the NYBCL, including
Section&nbsp;906 of Article 9 of the NYBCL, and this Merger Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-1- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;Subject to Article 9 hereof, the Merger shall become effective
upon the later of (x)&nbsp;(i) the acceptance for filing of the Delaware Certificate of Ownership and Merger (the &#147;<U>Delaware Certificate of Merger</U>&#148;), to be prepared and filed with the Secretary of State of the State of Delaware,
pursuant to Section&nbsp;253 of the DGCL and (ii)&nbsp;the acceptance for filing of the New York Certificate of Merger (the &#147;<U>New York Certificate of Merger</U>&#148;), to be prepared and filed with the New York Department of State, pursuant
to Sections 905 and 907(e) of the NYBCL, and (y)&nbsp;such other time as agreed upon by the parties and set forth in the Delaware Certificate of Merger and the New York Certificate of Merger (the &#147;<U>Effective Time</U>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;The parties intend, by executing this Merger Agreement, to adopt a plan of reorganization within the meaning of
Section&nbsp;368 of the Code; and to cause the Merger to qualify as a reorganization under the provisions of Section&nbsp;368(a)(1)(F) of the Code. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">ARTICLE 2.&nbsp;&nbsp;&nbsp;&nbsp;<U>Directors and Officers</U>. The parties will take all actions necessary so that the directors and
officers of Parent immediately prior to the Effective Time shall be the directors and officers of the Surviving Entity from and after the Effective Time, all of whom shall hold their directorships and offices until the election and qualification of
their respective successors or until their tenure is otherwise terminated in accordance with the <FONT STYLE="white-space:nowrap">by-laws</FONT> of the Surviving Entity, as the same may be amended from time to time, or the DGCL. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">ARTICLE 3.&nbsp;&nbsp;&nbsp;&nbsp;<U>Governing Documents</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;The certificate of incorporation of Subsidiary in effect immediately prior to the Effective Time, in the form
attached hereto as <U>Exhibit A</U>, shall be the certificate of incorporation of the Surviving Entity upon the Effective Time until amended in accordance with applicable law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;The <FONT STYLE="white-space:nowrap">by-laws</FONT> of Subsidiary in effect immediately prior to the Effective
Time, in the form attached hereto as <U>Exhibit B</U>, shall be the <FONT STYLE="white-space:nowrap">by-laws</FONT> of the Surviving Entity upon the Effective Time until amended in accordance with applicable law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">ARTICLE 4.&nbsp;&nbsp;&nbsp;&nbsp;<U>Name</U>. From and after the Effective Time, the name of the Surviving Entity shall be: <B><U>CONMED
Corporation</U></B>. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">ARTICLE 5.&nbsp;&nbsp;&nbsp;&nbsp;<U>Effect of Merger on Capital Stock</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;At the Effective Time, (i)&nbsp;each share of Parent Common Stock issued and outstanding immediately prior to the
Effective Time shall be automatically converted into one share of common stock of the Surviving Entity, and (ii)&nbsp;each issued and outstanding share of common stock of Subsidiary, all of which are owned by Parent, shall be automatically retired
and canceled, without the payment of consideration therefor. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;At the Effective Time, each option, restricted
stock unit, performance stock unit, stock appreciation right, convertible note or other security of Parent issued and outstanding immediately prior to the Effective Time shall be converted into and shall be an identical security of the Surviving
Entity, governed by the same terms and conditions (including with respect to vesting, performance goals and exercisability) as were applicable to such securities immediately prior to the Effective Time, and shares of common stock of the Surviving
Entity shall be reserved for issuance in connection with the vesting, exercise or conversion of such securities for each share of Parent Common Stock so reserved prior to the Effective Time. The exercise price or conversion ratio for each share of
common stock of the Surviving Entity issuable pursuant to any such option, restricted stock unit, performance stock unit, stock appreciation right, convertible note or other security of Parent shall be equal to the exercise price or conversion ratio
applicable to any such security of Parent at the Effective Time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;At and after the Effective Time, all of the
outstanding certificates or other documents that immediately prior to the Effective Time evidenced ownership of securities of Parent shall be deemed for all purposes to evidence ownership of and to represent the securities of the Surviving Entity
into which such securities of Parent have been converted, as herein provided, and shall be so registered on the books and records of the Surviving Entity or its transfer agent. The registered owner of any such outstanding certificate or other
document </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-2- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
evidencing ownership of securities of Parent shall, until such certificate or other document shall have been surrendered for transfer or otherwise accounted for to the Surviving Entity or its
transfer agent, have and be entitled to exercise any voting and other rights with respect to, and to receive any dividends and other distributions upon, the securities evidenced by such certificate or other document, as above provided. Each
certificate representing capital stock of the Surviving Entity issued in the Merger shall bear the same legends, if any, with respect to the restrictions on transferability as the certificates of Parent so converted and given in exchange therefor,
unless otherwise determined by the Board of Directors of the Surviving Entity in compliance with applicable laws, and any additional legends required by applicable blue sky laws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;All shares of common stock of the Surviving Entity into which shares of Parent Common Stock are to be converted
pursuant to the Merger shall not be subject to any statutory or contractual preemptive rights, shall, when issued, be validly issued, fully paid and <FONT STYLE="white-space:nowrap">non-assessable</FONT> and shall be issued in full satisfaction of
all rights pertaining to such Parent Common Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">ARTICLE 6.&nbsp;&nbsp;&nbsp;&nbsp;<U>Transfer, Conveyance and Assumption</U>. Without
limiting the generality of the foregoing, at the Effective Time, (i)&nbsp;the Surviving Entity shall, without further transfer, succeed to and possess all of the rights, privileges, franchises, immunities and powers of Parent; (ii)&nbsp;the
Surviving Entity shall be subject to all actions previously taken by Parent&#146;s Board of Directors; (iii)&nbsp;all of the assets and property of whatever kind and character of Parent shall vest in the Surviving Entity without further act or deed;
and (iv)&nbsp;the Surviving Entity shall, without further act or deed, assume and be subject to all of the duties, liabilities, obligations and restrictions of every kind and description of Parent, including, without limitation, all outstanding
indebtedness of Parent. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">ARTICLE 7.&nbsp;&nbsp;&nbsp;&nbsp;<U>Employee Benefit and Compensation Plans</U>. At the Effective Time, each
employee benefit plan, incentive compensation plan and other similar plans to which Parent is then a party (the &#147;<U>Plans</U>&#148;) shall be assumed by, and continue to be the plan of, the Surviving Entity, and Surviving Entity shall assume,
as of the Effective Time, all obligations of Parent under the Plans, including (i)&nbsp;the outstanding options, restricted stock units, performance stock units, stock appreciation rights or other awards or portions thereof granted pursuant to the
Plans and the right to grant additional awards thereunder and (ii)&nbsp;all obligations of Parent under the Plans with respect to which employee rights or accrued benefits are outstanding as of the Effective Time (including, for the avoidance of
doubt, any change in control or severance plan, agreement or arrangement). To the extent any Plan provides for the issuance or purchase of, or otherwise relates to, securities of Parent, after the Effective Time such plan shall be deemed to provide
for the issuance or purchase of, or otherwise relate to, the securities of the Surviving Entity into which such securities of Parent have been converted as herein provided. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">ARTICLE 8.&nbsp;&nbsp;&nbsp;&nbsp;<U>Further Assurances</U>. In the event that this Merger Agreement shall have been duly adopted by the
shareholders of Parent in accordance with Article 9, Parent and Subsidiary agree that they will cause to be executed and filed and recorded any document or documents prescribed by the laws of the State of New York and by the laws of the State of
Delaware, and that they will cause to be performed all necessary acts within the State of New York and the State of Delaware and any other applicable jurisdiction, in each case to effectuate the Merger pursuant to the terms set forth in this Merger
Agreement. The directors and officers of the Parent and Subsidiary are fully authorized, empowered and directed to do any and all acts and things, and to make, execute, deliver, file, and record any and all instruments, papers, and documents which
shall be or become necessary, proper, or convenient to carry out or put into effect any of the provisions of this Merger Agreement and the transactions contemplated hereby, including the Merger. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">ARTICLE 9.&nbsp;&nbsp;&nbsp;&nbsp;<U>Shareholder Approval; Termination</U>. This Merger Agreement shall be submitted to a vote of the
shareholders of Parent in accordance with the laws of the State of New York and Parent&#146;s certificate of incorporation and <FONT STYLE="white-space:nowrap">by-laws.</FONT> In the event that this Merger Agreement shall not be adopted by the
requisite vote of the shareholders of Parent entitled to vote thereon, this Merger Agreement shall thereupon be terminated without further action of the parties hereto. Notwithstanding anything to the contrary set forth in this Merger Agreement
(including the provisions of <U>Article 8</U>), this Merger Agreement may also be terminated by Parent before or after shareholder approval thereof, and the Merger may be abandoned, at any time prior to the Effective Time, if the Board of Directors
of Parent determines for any reason, in its sole judgment and discretion, that the consummation of the Merger would be inadvisable or not in the best interests of Parent and its shareholders. In the event of the termination and abandonment of this
Merger Agreement, this Merger Agreement shall become null and void and have no effect, without any liability on the part of either Parent or Subsidiary, or any of their respective shareholders, stockholders, directors or officers. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-3- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">ARTICLE 10.&nbsp;&nbsp;&nbsp;&nbsp;<U>Amendments; Waivers</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;Any provision of this Merger Agreement may, subject to applicable law, be amended or waived prior to the Effective
Time if, and only if, such amendment or waiver is in writing and signed by Parent and Subsidiary, provided that, following the adoption of the Merger Agreement by the requisite vote of the shareholders of Parent entitled to vote therein, an
amendment shall not (i)&nbsp;alter or change the amount or kind of shares, securities, cash, property and/or rights to be received in exchange for or on conversion of all or any securities of Parent to be effected by the Merger; (ii)&nbsp;alter or
change any term of the certificate of incorporation of the Surviving Entity; or (iii)&nbsp;alter or change any of the terms and conditions of this Merger Agreement if such alteration or change would adversely affect the holders of any equity
securities of Parent. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;No failure or delay by any party hereto in exercising any right, power or privilege
hereunder shall operate as a waiver thereof nor shall any single or partial exercise thereof preclude any other or further exercise thereof or the exercise of any other right, power or privilege. The rights and remedies herein provided shall be
cumulative and not exclusive of any rights or remedies provided by law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">ARTICLE 11.&nbsp;&nbsp;&nbsp;&nbsp;<U>No Third Party
Beneficiaries</U>. The provisions of this Merger Agreement are solely for the benefit of the parties hereto and this Merger Agreement is not intended to, and does not, confer upon any person other than the parties, and their respective successors
and permitted assigns, any rights or remedies, express or implied, hereunder, including the right to rely upon or enforce any of the provisions of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">ARTICLE 12.&nbsp;&nbsp;&nbsp;&nbsp;<U>Successors and Assigns</U>. The provisions of this Merger Agreement shall be binding upon and inure to
the benefit of the parties hereto and their respective successors and assigns, provided that no party may assign, delegate or otherwise transfer any of its rights or obligations under this Merger Agreement without the consent of the other party
hereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">ARTICLE 13.&nbsp;&nbsp;&nbsp;&nbsp;<U>Governing Law</U>. This Merger Agreement and all claims or causes of action arising out of
or relating to this Merger Agreement shall be governed by, and interpreted and construed in accordance with, the laws of the State of Delaware, without regard to principles of conflicts of law, except to the extent that the laws of the State of New
York are mandatorily applicable to the Merger. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">ARTICLE 14.&nbsp;&nbsp;&nbsp;&nbsp;<U>Counterparts; Effectiveness</U>. This Merger
Agreement may be executed in any number of counterparts, each such counterpart being deemed to be an original instrument, and all such counterparts shall together constitute the same agreement. A signed copy of this Merger Agreement delivered by
facsimile, email or other means of electronic transmission shall be deemed to have the same legal effect as delivery of an original signed copy of this Merger Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">ARTICLE 15.&nbsp;&nbsp;&nbsp;&nbsp;<U>Severability</U>. The provisions of this Merger Agreement shall be deemed severable and the invalidity
or unenforceability of any provision shall not affect the validity or enforceability of the other provisions hereof. If any provision of this Merger Agreement, or the application thereof to any person or any circumstance, is determined by any court
or other authority of competent jurisdiction to be invalid or unenforceable, (a)&nbsp;a suitable and equitable provision shall be substituted therefor in order to carry out, so far as may be valid and enforceable, the intent and purpose of such
invalid or unenforceable provision and (b)&nbsp;the remainder of this Merger Agreement and the application of such provision to other persons or circumstances shall not be affected by such invalidity or unenforceability, nor shall such invalidity or
unenforceability affect the validity or enforceability of such provision, or the application thereof, in any other jurisdiction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature page follows</I>] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-4- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the undersigned, being authorized officers of the constituent
corporations, have executed this Merger Agreement as of the date first written above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>PARENT:</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">CONMED Corporation,</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><I>a New York corporation</I></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Curt R. Hartman</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Curt R. Hartman</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">President and Chief Executive Officer</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="32" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>SUBSIDARY / SURVIVING ENTITY:</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">CONMED Corporation,</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><I>a Delaware corporation</I></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Daniel S. Jonas</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Daniel S. Jonas</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Executive Vice President, Legal Affairs, General Counsel&nbsp;&amp; Secretary</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to
Merger Agreement (Reincorporation)</I>] </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.1
<SEQUENCE>3
<FILENAME>d193269dex31.htm
<DESCRIPTION>EX-3.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-3.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 3.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">EXECUTION VERSION </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">CERTIFICATE OF
INCORPORATION </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">OF </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">CONMED
CORPORATION </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">FIRST. The name of the corporation is CONMED Corporation (the &#147;Corporation&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">SECOND. The purpose of the Corporation is to engage in any lawful act or activity for which corporations may be organized under the General
Corporation Law of the State of Delaware. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">THIRD. The registered office of the Corporation in the State of Delaware is to be located at
Corporation Trust Center, 1209 Orange Street in the City of Wilmington, County of New Castle, 19801. The name of its registered agent at such address is The Corporation Trust Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">FOURTH. The total number of shares of all classes of stock which the Corporation shall have the authority to issue is 100,500,000, of which
100,000,000 shares of the par value of $.01 per share shall be designated as common stock (&#147;Common Stock&#148;) and 500,000 shares of the par value of $.01 per share shall be designated as preferred stock (&#147;Preferred Stock&#148;). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:11%; font-size:10pt; font-family:Times New Roman">1.&nbsp;&nbsp;&nbsp;&nbsp;Shares of Preferred Stock may be issued in one or more series from time to time by the Board of
Directors, and the Board of Directors is expressly authorized to fix by resolution the designations and the powers, preferences and rights, and the qualifications, limitations and restrictions, of the shares of each series of Preferred Stock,
including without limitation the following: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;the distinctive serial designation of such series
which shall distinguish it from other series; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;the number of shares included in such series;
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;the dividend rate (or method of determining such rate) payable to the holders of the shares of
such series, any conditions upon which such dividends shall be paid and the date or dates upon which such dividends shall be payable; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;whether dividends on the shares of such series shall be cumulative and, in the case of shares of
any series having cumulative dividend rights, the date or dates or method of determining the date or dates from which dividends on the shares of such series shall be cumulative; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;the amount or amounts which shall be payable out of the assets of the Corporation to the holders of
the shares of such series upon voluntary or involuntary liquidation, dissolution or winding up the Corporation, and the relative rights of priority, if any, of payment of the shares of such series; </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f)&nbsp;&nbsp;&nbsp;&nbsp;the price or prices at which, the period or
periods within which and the terms and conditions upon which the shares of such series may be redeemed, in whole or in part, at the option of the Corporation or at the option of the holder or holders thereof or upon the happening of a specified
event or events; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g)&nbsp;&nbsp;&nbsp;&nbsp;the obligation, if any, of the Corporation to purchase or redeem shares of
such series pursuant to a sinking fund or otherwise and the price or prices at which, the period or periods within which and the terms and conditions upon which the shares of such series shall be redeemed or purchased, in whole or in part, pursuant
to such obligation; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h)&nbsp;&nbsp;&nbsp;&nbsp;whether or not the shares of such series shall be convertible or
exchangeable, at any time or times at the option of the holder or holders thereof or at the option of the Corporation or upon the happening of a specified event or events, into shares of any other class or classes or any other series of the same or
any other class or classes of stock of the Corporation, and the price or prices or rate or rates of exchange or conversion and any adjustments applicable thereto; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;whether or not the holders of the shares of such series shall have voting rights, in addition to
the voting rights provided by law, and if so the terms of such voting rights; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j)&nbsp;&nbsp;&nbsp;&nbsp;any other
powers, preferences and rights and qualifications, limitations and restrictions not inconsistent with the General Corporation Law of the State of Delaware. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:11%; font-size:10pt; font-family:Times New Roman">2.&nbsp;&nbsp;&nbsp;&nbsp;All Preferred Stock redeemed, purchased or otherwise acquired by the Corporation (including shares
surrendered for conversion or exchange or acquired by exchange or otherwise) shall be cancelled and thereupon restored to the status of authorized but unissued shares of Preferred Stock undesignated as to series. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:11%; font-size:10pt; font-family:Times New Roman">3.&nbsp;&nbsp;&nbsp;&nbsp;No holder of Common Stock or of Preferred Stock shall be entitled as a matter of right to subscribe
for, purchase or receive, or have any preferential or pre-emptive right with respect to, any part of any new or additional issue of stock of any class or series whatsoever, or any options or warrants for such stock, or any rights to subscribe for or
purchase such stock, or of securities convertible into or exchangeable for any stock of any class or series whatsoever, whether now or hereafter authorized and whether issued for cash or other consideration or by way of dividend or otherwise. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:11%; font-size:10pt; font-family:Times New Roman">4.&nbsp;&nbsp;&nbsp;&nbsp;Unless otherwise provided in the resolution or resolutions of the Board of Directors or a duly
authorized committee thereof establishing the terms of a series of Preferred Stock, no holder of any share of Preferred Stock shall be entitled as of right to vote on any amendment or alteration of the Certificate of Incorporation to authorize or
create, or increase the authorized number of shares of, any other series of Preferred Stock or any alteration, amendment or repeal of any provision of any other series of Preferred Stock that does not adversely affect in any material respect the
rights of the series of Preferred Stock held by such holder. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-2- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:11%; font-size:10pt; font-family:Times New Roman">5.&nbsp;&nbsp;&nbsp;&nbsp;Except as otherwise required by the General
Corporation Law of Delaware or provided in the resolution or resolutions of the Board of Directors or a duly authorized committee thereof establishing the terms of a series of Preferred Stock, no holder of Common Stock, as such, shall be entitled to
vote on any amendment or alteration of the Certificate of Incorporation that alters, amends or changes the powers, preferences, rights or other terms of one or more outstanding series of Preferred Stock if the holders of such affected series are
entitled, either separately or together with the holders of one or more other series of Preferred Stock, to vote thereon pursuant to the Certificate of Incorporation or pursuant to the General Corporation Law of the State of Delaware. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:11%; font-size:10pt; font-family:Times New Roman">6.&nbsp;&nbsp;&nbsp;&nbsp;Except as may from time to time be required by law and except as otherwise may be provided by the
Board of Directors in accordance with paragraph 1 of this Article FOURTH in respect of any particular series of Preferred Stock, all voting rights of the Corporation shall be vested exclusively in the holders of the Common Stock who shall be
entitled to one vote per share on all matters. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:11%; font-size:10pt; font-family:Times New Roman">7.&nbsp;&nbsp;&nbsp;&nbsp;Subject to the rights of the holders of any
outstanding series of Preferred Stock, the number of authorized shares of Preferred Stock or any series of Preferred Stock of the Corporation may be increased or decreased (but not below the number of shares thereof then outstanding) by the
affirmative vote of at least a majority of the voting power of all classes of stock entitled to vote thereon irrespective of the provisions of Section&nbsp;242(b)(2) of the General Corporation Law of the State of Delaware. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:11%; font-size:10pt; font-family:Times New Roman">8.&nbsp;&nbsp;&nbsp;&nbsp;Unless otherwise provided in the resolution or resolutions of the Board of Directors or a duly
authorized committee thereof establishing the terms of a series of Preferred Stock, no holder of any share of Preferred Stock shall, in such capacity, be entitled to bring a derivative action, suit or proceeding on behalf of the Corporation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">FIFTH. All actions required or permitted to be taken by the stockholders at an annual or special meeting of stockholders of the Corporation
may be taken without a meeting, without prior notice and without a vote if a consent or consents in writing, setting forth the action so taken, shall be signed by the holders of record of the outstanding shares of the Corporation having not less
than the minimum number of votes that would be necessary to authorize or take such action at a meeting at which all shares entitled to vote thereon were present and voted and shall be delivered to the Corporation in accordance with this Article
FIFTH and applicable law, provided that no such action by written consent may be effected except in accordance with this Article FIFTH and applicable law. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:11%; font-size:10pt; font-family:Times New Roman">1.&nbsp;&nbsp;&nbsp;&nbsp;<U>Request for Record Date</U>. The record date for determining the stockholders entitled to consent
to a corporate action in writing without a meeting shall be as fixed by the Board of Directors or as otherwise established under this Article FIFTH. Any stockholder(s) of record seeking to have the stockholders of the Corporation authorize or take
action by written consent without a meeting shall, by written notice addressed to the Secretary, delivered to the Corporation at its principal executive office and signed by holders of record at the time such notice is delivered beneficially owning
shares representing in the aggregate at least twenty-five percent of the outstanding shares of capital stock of the Corporation, provided that such shares are determined to be &#147;Net Long </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-3- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
Shares&#148; (as defined in Section&nbsp;1.2(b)(i) of the <FONT STYLE="white-space:nowrap">by-laws</FONT> of the Corporation, as may be amended from time to time) that have been held continuously
for at least one year prior to the date of the written request (the &#147;Requisite Percentage&#148;), request that a record date be fixed for such purpose. For purposes of this Article FIFTH, the word &#147;beneficially owned&#148; has the meaning
ascribed thereto in Rules <FONT STYLE="white-space:nowrap">13d-3</FONT> and <FONT STYLE="white-space:nowrap">13d-5</FONT> under the Exchange Act. Such request must contain the information set forth in paragraph (2)&nbsp;of this Article FIFTH.
Following receipt of such request, the Board of Directors shall, by the later of (i)&nbsp;twenty days after the Corporation&#146;s receipt of such request and (ii)&nbsp;ten days after delivery of any information requested by the Corporation to
determine the validity of any such request or whether the request relates to an action that may be taken by written consent pursuant to this Article FIFTH and applicable law, determine the validity of such request and, if appropriate, adopt a
resolution fixing the record date for such purpose. The record date for such purpose shall be no more than ten days after the date upon which the resolution fixing the record date is adopted by the Board of Directors and shall not precede the date
upon which such resolution is adopted. If the request required by this paragraph (1)&nbsp;has been determined to be valid and to relate to an action that may be effected by written consent pursuant to this Article FIFTH and applicable law or if no
such determination shall have been made by the date required by this paragraph (1), and in either event no record date has been fixed by the Board of Directors, the record date shall be the first date on which a signed written consent relating to
the action taken or proposed to be taken by written consent is delivered to the Corporation in the manner described in paragraph (5)&nbsp;of this Article FIFTH; provided, that if prior action by the Board of Directors is required by applicable law,
the record date shall be at the close of business on the day on which the Board of Directors adopts the resolution taking such prior action. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; text-indent:11%; font-size:10pt; font-family:Times New Roman">2.&nbsp;&nbsp;&nbsp;&nbsp;<U>Request Requirements</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:15%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;Any request required by paragraph (1)&nbsp;of this Article FIFTH must be delivered by the holders
of record of at least the Requisite Percentage, who shall not revoke such request and who shall continue to beneficially own not less than the Requisite Percentage through the date of delivery of consents signed by a sufficient number of
stockholders to authorize or take such action, and must: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:18%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;contain an agreement to solicit
consents in accordance with subsection (4)&nbsp;of this Article FIFTH; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:18%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii)&nbsp;&nbsp;&nbsp;&nbsp;describe the action
proposed to be taken by written consent of stockholders (including the text of any resolutions to be adopted by written consent of stockholders and the language of any proposed amendment to the <FONT STYLE="white-space:nowrap">by-laws</FONT> of the
Corporation) </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:18%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii)&nbsp;&nbsp;&nbsp;&nbsp;contain (x)&nbsp;in the case of any matter (other than a director nomination)
proposed to be taken by written consent of stockholders, the information required by Sections 1.13(b)(ii)(A) and (B)&nbsp;of the <FONT STYLE="white-space:nowrap">by-laws</FONT> of the Corporation, and (y)&nbsp;in the case of any director nominations
proposed to be elected by written consent of stockholders, the information required by Sections 1.13(b)(ii)(A), (C) and (D), and Section&nbsp;1.14(d) of the <FONT STYLE="white-space:nowrap">by-laws</FONT> of the Corporation; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-4- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv)&nbsp;&nbsp;&nbsp;&nbsp;set forth the calculation of the requesting
stockholder(s)&#146; Net Long Shares, including the number of shares held of record and disclosure of any short positions, hedges, voting or other arrangements that impact the calculation of such Net Long Shares; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:18%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v)&nbsp;&nbsp;&nbsp;&nbsp;include an agreement by the requesting stockholder(s) to notify the Corporation immediately in the
case of any disposition prior to the record date set for the action by written consent of any Net Long Shares beneficially owned of record and an acknowledgement that any such disposition shall be deemed a revocation of such request to the extent of
such disposition, such that the number of shares disposed of shall not be included in determining whether the Requisite Percentage has been reached and maintained; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:18%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(vi)&nbsp;&nbsp;&nbsp;&nbsp;include documentary evidence that the requesting stockholder(s) beneficially own in the aggregate
not less than the Requisite Percentage as of the date of such written request to the Secretary; provided, however, that if the stockholder(s) making the request are not the beneficial owners of the shares representing the Requisite Percentage, then
to be valid, the request must also include documentary evidence (or, if not simultaneously provided with the request, such documentary evidence must be delivered to the Secretary within ten business days after the date on which the request is
delivered to the Secretary) that the beneficial owners on whose behalf the request is made beneficially own at least the Requisite Percentage as of the date on which such request is delivered to the Secretary. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:15%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;The Corporation may require the stockholder(s) submitting such request to furnish such other
information as may be reasonably requested by the Corporation. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:15%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp; Any requesting stockholder may
revoke his, her or its request at any time by written revocation delivered to the Secretary at the principal executive offices of the Corporation; provided, however, that if at any time following such revocation (including any revocation resulting
from a disposition of shares), the unrevoked valid requests represent in the aggregate less than the Requisite Percent, the Board of Directors, in its discretion, may cancel the action by written consent and revoke the fixing of the record date
established in connection therewith. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:11%; font-size:10pt; font-family:Times New Roman">3.&nbsp;&nbsp;&nbsp;&nbsp;<U>Actions Which May Be Taken by Written Consent</U>.
Stockholders are not entitled to act by written consent in lieu of a meeting of stockholders if (i)&nbsp;the request to act by written consent made pursuant to paragraph (1)&nbsp;of this Article FIFTH (x)&nbsp;does not comply with this Article
FIFTH, (y)&nbsp;was made in a manner that involved a violation of Regulation 14A under the Exchange Act or other applicable law, or (z)&nbsp;relates to an item of business that is not a proper subject for stockholder action under applicable law,
(ii)&nbsp;any </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-5- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
such request is received by the Corporation during the period commencing ninety days before the first anniversary of the date of the immediately preceding annual meeting of stockholders and
ending on the date of the next annual meeting of stockholders, (iii)&nbsp;an identical or substantially similar item (as determined by the Board of Directors, a &#147;Similar Item&#148;), other than the election or removal of directors, was
presented at a meeting of stockholders held not more than twelve months before the request for a record date for such action is delivered to the Corporation, (iv)&nbsp;a Similar Item consisting of the election or removal of directors was presented
at a meeting of stockholders held not more than ninety days before the request for a record date was delivered to the Corporation (and, for purposes of this clause, the election or removal of directors shall be deemed a &#147;Similar Item&#148; with
respect to all items of business involving the election or removal of directors, changing the size of the Board of Directors and the filling of vacancies and/or newly created directorships resulting from any increase in the authorized number of
directors), or (v)&nbsp;a Similar Item is included in the Corporation&#146;s notice of meeting as an item of business to be brought before an annual or special meeting of stockholders that has been called but not yet held or that is called within
ninety days after the request is received by the Secretary. The Board of Directors shall determine whether a record date is required to be set under this Article FIFTH. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:11%; font-size:10pt; font-family:Times New Roman">4.&nbsp;&nbsp;&nbsp;&nbsp;<U>Manner of Consent Solicitation</U>. Stockholders may take action by written consent only if
consents are solicited by the stockholder(s) seeking to take action by written consent from all holders of capital stock of the Corporation entitled to vote on the matter in accordance with this Article FIFTH, the
<FONT STYLE="white-space:nowrap">by-laws</FONT> of the Corporation, Regulation 14A of the Exchange Act, without reliance upon the exemption contained in Rule <FONT STYLE="white-space:nowrap">14a-2(b)(2)</FONT> of the Exchange Act, and applicable
law. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:11%; font-size:10pt; font-family:Times New Roman">5.&nbsp;&nbsp;&nbsp;&nbsp;<U>Timing of Delivery</U>. No written consent purporting to take or authorize the taking
of a corporate action (each such written consent is referred to in this paragraph (5)&nbsp;and in paragraph (6)&nbsp;of this Article FIFTH as a &#147;Consent&#148;) shall be effective to take the corporate action referred to therein unless Consents
signed by a sufficient number of stockholders to take such action are delivered to the Corporation in the manner required by paragraph (6)&nbsp;of this Article FIFTH within sixty days of the first date on which a Consent is so delivered to the
Corporation. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:11%; font-size:10pt; font-family:Times New Roman">6.&nbsp;&nbsp;&nbsp;&nbsp;<U>Delivery of Consents</U>. No Consents may be dated or delivered to the
Corporation or its registered office in the State of Delaware until the date that is sixty days after the date of delivery of a valid request to set a record date. Consents must be delivered to the Corporation by delivery to its registered office in
the State of Delaware or its principal place of business. Delivery must be made by hand or by certified or registered mail, return receipt requested. In the event of the delivery to the Corporation of Consents, the Secretary or such other officer of
the Corporation or inspector as the Board of Directors may designate shall provide for the safe-keeping of such Consents and any related revocations and shall promptly conduct such ministerial review of the sufficiency of all Consents and any
related revocations and of the validity of the action to be taken by written consent as the Secretary or such other officer of the Corporation, as the case may be, deems necessary or appropriate, including, without limitation, whether the
stockholders of a number of shares having the requisite voting power to authorize or take the action specified </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-6- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
in the Consents have given their valid and duly executed consent to the taking of such action; provided, however, that if the action to which the Consents relate is the election or removal of one
or more members of the Board of Directors, the Secretary or such other officer of the Corporation, as the case may be, shall promptly designate two persons, who shall not be members of the Board of Directors, to serve as inspectors (the
&#147;Inspectors&#148;) with respect to such Consent, and such Inspectors shall discharge the functions of the Secretary or such other officer of the Corporation, as the case may be, under this Article FIFTH. If, after such investigation, the
Secretary, such other officer of the Corporation or the Inspectors, as the case may be, determines that the action purported to have been taken is duly authorized by the Consents, that fact shall be certified on the records of the Corporation kept
for the purpose of recording the proceedings of meetings of stockholders and the Consents shall be filed in such records. In conducting the investigation required by this section, the Secretary, such other officer of the Corporation or the
Inspectors, as the case may be, may, at the expense of the Corporation, retain special legal counsel and any other necessary or appropriate professional advisors as such person or persons may deem necessary or appropriate and, to the fullest extent
permitted by law, shall be fully protected in relying in good faith upon the opinion of such counsel or advisors. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:11%; font-size:10pt; font-family:Times New Roman">7.&nbsp;&nbsp;&nbsp;&nbsp;<U>Effectiveness of Consent</U>. Notwithstanding anything in this Certificate of Incorporation to
the contrary, no action may be taken by written consent of the stockholders except in accordance with this Article FIFTH and applicable law. If the Board of Directors shall determine that any request to fix a record date or to take stockholder
action by written consent was not properly made in accordance with, or relates to an action that may not be effected by written consent pursuant to, this Article FIFTH or applicable law, or the stockholder(s) seeking to take such action do not
otherwise comply with this Article FIFTH or applicable law, then the Board of Directors shall not be required to fix a record date in respect of such proposed action, and any such purported action by written consent shall be null and void. No action
by written consent without a meeting shall be effective until such date as the Secretary, such other officer of the Corporation as the Board of Directors may designate or the Inspectors, as applicable, certify to the Corporation that the Consents
delivered to the Corporation in accordance with paragraph (6)&nbsp;of this Article FIFTH represent at least the minimum number of votes that would be necessary to take the corporate action at a meeting at which all shares entitled to vote thereon
were present and voted, in accordance with applicable law and this Certificate of Incorporation. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:11%; font-size:10pt; font-family:Times New Roman">8.&nbsp;&nbsp;&nbsp;&nbsp;<U>Challenge to Validity of Consent</U>. Nothing contained in this Article FIFTH shall in any way be
construed to suggest or imply that the Board of Directors or any stockholder shall not be entitled to contest the validity of any Consent or related revocations, whether before or after such certification by the Secretary, such other officer of the
Corporation as the Board of Directors may designate or the Inspectors, as the case may be, or to take any other action with respect thereto (including, without limitation, the commencement, prosecution, or defense of any litigation, and the seeking
of injunctive relief in such litigation). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:11%; font-size:10pt; font-family:Times New Roman">9.&nbsp;&nbsp;&nbsp;&nbsp;<U>Board-Solicited Stockholder Action by Written
Consent</U>. Notwithstanding anything to the contrary set forth above, (x)&nbsp;none of the foregoing provisions of this Article FIFTH shall apply to any solicitation of stockholder action by written consent in lieu of a meeting by or at the
direction of the Board of Directors and (y)&nbsp;the Board of Directors shall be entitled to solicit stockholder action by written consent in accordance with applicable law. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-7- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">SIXTH. Elections of directors need not be by written ballot except and to the extent
provided in the <FONT STYLE="white-space:nowrap">by-laws</FONT> of the Corporation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">SEVENTH. The number of directors of the Corporation
shall be fixed from time to time in the manner provided in the <FONT STYLE="white-space:nowrap">by-laws</FONT> of the Corporation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">EIGHTH. A director of the Corporation shall not be liable to the Corporation or its stockholders for monetary damages for breach of fiduciary
duty as a director, except to the extent that such exemption from liability or limitation thereof is not permitted under the Delaware General Corporation Law as currently in effect or as the same may hereafter be amended. No amendment, modification
or repeal of this Article EIGHTH shall adversely affect any right or protection of a director that exists at the time of such amendment, modification or repeal. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">NINTH. The Corporation shall, to the fullest extent permitted by Section&nbsp;145 of the Delaware General Corporation Law as currently in
effect or as the same may hereafter be amended, indemnify directors and officers from and against any and all of the expenses, liabilities or other matters referred to in or covered by said section. The indemnification provided for herein shall not
be deemed exclusive of any other rights to which those seeking indemnification may be entitled under any <FONT STYLE="white-space:nowrap">by-law,</FONT> agreement, vote of stockholders or disinterested directors or otherwise. No amendment,
modification or repeal of this Article NINTH shall adversely affect any right or protection of a director that exists at the time of such amendment, modification or repeal. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">TENTH. The name and mailing address of the incorporator is Daniel S. Jonas, Esq., c/o CONMED Corporation, 525 French Road, Utica, New York
13502. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">ELEVENTH. The power to adopt, amend or repeal the <FONT STYLE="white-space:nowrap">by-laws</FONT> of the Corporation shall be
vested in the Board of Directors and the stockholders of the Corporation entitled to vote in the election of directors. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-8- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, I have signed this Certificate of Incorporation this 16th day of April,
2020. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Daniel S. Jonas</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Daniel S. Jonas, Esq.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Incorporator</TD></TR>
</TABLE></DIV>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.2
<SEQUENCE>4
<FILENAME>d193269dex32.htm
<DESCRIPTION>EX-3.2
<TEXT>
<HTML><HEAD>
<TITLE>EX-3.2</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 3.2 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT STYLE="white-space:nowrap">BY-LAWS</FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">OF </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">CONMED CORPORATION </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Effective April&nbsp;16, 2020 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE I </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>Stockholders
</U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.1.&nbsp;&nbsp;&nbsp;&nbsp;<U>Annual Meeting</U>. A meeting of stockholders shall be held annually for the election of
directors and the transaction of other business on such date, time and place either within or without the State of Delaware, or may not be held at any place, but may instead be held solely by means of remote communication, as may be designated by
the Board of Directors (the &#147;Board&#148;) of CONMED Corporation (the &#147;Corporation&#148;) from time to time. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.2.&nbsp;&nbsp;&nbsp;&nbsp;<U>Special Meetings</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;Special meetings of the stockholders of the Corporation may be called at any time by the Board, the Chair of the
Board, if any, the Lead Independent Director, if any, the President or by stockholders of the Corporation as provided in this Section&nbsp;1.2, in each case to be held at such date, time and place either within or without the State of Delaware, or
may not be held at any place, but may instead be held by means of remote communication, as may be stated in the notice of the meeting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;A special meeting of the stockholders (a &#147;Stockholder Requested Special Meeting&#148;) shall be called by the
Secretary upon the written request (each, a &#147;Special Meeting Request&#148;) of one or more stockholders who have continuously held of record for at least one year as of the date of the Secretary&#146;s receipt of the request to call a special
meeting &#147;Net Long Shares&#148; (as defined in clause (i)&nbsp;of this Section&nbsp;1.2(b)) representing in the aggregate at least twenty-five percent (25%) of the voting power of all outstanding shares of capital stock of the Corporation
entitled to vote on the matter or matters to be brought before the proposed special meeting (such Net Long Shares held for the requisite period, the &#147;Requisite Percentage&#148;) subject to the following: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;For purposes of calculating the Requisite Percentage, a requesting stockholder&#146;s &#147;Net Long
Shares&#148; shall be limited to the number of shares beneficially owned, directly or indirectly, by each requesting stockholder that constitute such stockholder&#146;s &#147;net long position&#148; as defined in Rule
<FONT STYLE="white-space:nowrap">14e-4</FONT> under the Exchange Act; provided that (i)&nbsp;for the purposes of such definition, reference in such rule to (A) &#147;the date that a tender offer is first publicly announced or otherwise made known by
the bidder to holders of the security to be acquired&#148; shall be the date of the Secretary&#146;s receipt of the relevant Special Meeting Request, (B)&nbsp;the &#147;highest tender offer price or stated amount of the consideration offered for the
subject security&#148; shall refer to the closing sales price of the Company&#146;s common stock on the New York Stock Exchange (or such other securities exchange designated by the Board if the Company&#146;s common stock is not then listed for
trading on the New York Stock Exchange) on such date (or, if such date is not a trading day, the next succeeding trading day), (C) the &#147;person whose securities are the subject of the offer&#148; shall refer to the Company, and (D) &#147;subject
security&#148; shall refer to the issued </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
and outstanding common stock of the Company; and (ii)&nbsp;the net long position of such stockholder shall be reduced by the number of shares as to which the Board determines such stockholder
does not, or will not, have the right to vote on its own behalf at the proposed special meeting or as to which the Board determines that such shareholder has entered into any derivative or other agreement, arrangement, or understanding that hedges
or transfers, in whole or in part, directly or indirectly, any of the economic consequences of ownership of such shares. In addition, to the extent any affiliates of the stockholder or beneficial owner are acting in concert with the stockholder or
beneficial owner with respect to the calling of the special meeting, the determination of Net Long Shares may include the effect of aggregating the Net Long Shares (including any negative number) of such affiliate or affiliates. Whether shares
constitute Net Long Shares shall be determined in good faith by the Board. For purposes of this Section&nbsp;1.2, the word &#147;beneficially owned&#148; has the meaning ascribed thereto in Rules <FONT STYLE="white-space:nowrap">13d-3</FONT> and <FONT
STYLE="white-space:nowrap">13d-5</FONT> under the Exchange Act. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii)&nbsp;&nbsp;&nbsp;&nbsp;In order for a Stockholder
Requested Special Meeting to be called by the Secretary, one or more Special Meeting Requests stating the purpose of the special meeting and the matters proposed to be acted upon at such meeting must be signed and dated by the Requisite Percentage
of record holders of the common stock of the Corporation (or their duly authorized agents), must be delivered to the Secretary at the principal executive offices of the Corporation and must: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A)&nbsp;&nbsp;&nbsp;&nbsp;describe the specific purpose(s) of the meeting and the matters proposed to be acted on at such
special meeting (including the text of any resolutions proposed for consideration and the language of any proposed amendment to these <FONT STYLE="white-space:nowrap">by-laws);</FONT> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B)&nbsp;&nbsp;&nbsp;&nbsp;contain (x)&nbsp;in the case of any matter (other than a director nomination) proposed to be
conducted at such Stockholder Requested Special Meeting, the information required by Sections 1.13(b)(ii)(A) and (B)&nbsp;of these <FONT STYLE="white-space:nowrap">by-laws,</FONT> and (y)&nbsp;in the case of any director nominations proposed to be
presented at such Stockholder Requested Special Meeting, the information required by Sections 1.13(b)(ii)(A), (C) and (D), and Section&nbsp;1.14(d) of these <FONT STYLE="white-space:nowrap">by-laws;</FONT> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(C)&nbsp;&nbsp;&nbsp;&nbsp;set forth the calculation of the requesting stockholder&#146;s Net Long Shares, including the number
of shares held of record and disclosure of any short positions, hedges, voting or other arrangements that impact the calculation of such Net Long Shares; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(D)&nbsp;&nbsp;&nbsp;&nbsp;include an agreement by the requesting stockholder(s) to notify the Corporation immediately in the
case of any reduction prior to the record date for the Stockholder Requested Special Meeting of any Net Long Shares beneficially owned of record and an acknowledgement that any such disposition shall be deemed a revocation of such Special Meeting
Request to the extent of such disposition, such that the number of shares disposed of shall not be included in determining whether the Requisite Percentage has been reached and maintained; and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-2- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(E)&nbsp;&nbsp;&nbsp;&nbsp;include documentary evidence that the requesting
stockholder(s) beneficially own in the aggregate not less than the Requisite Percentage as of the date of such Special Meeting Request to the Secretary; provided, however, that if the stockholder(s) making the request are not the beneficial owners
of the shares representing the Requisite Percentage, then to be valid, the Special Meeting Request must also include documentary evidence (or, if not simultaneously provided with the request, such documentary evidence must be delivered to the
Secretary within ten business days after the date on which the request is delivered to the Secretary) that the beneficial owners on whose behalf the request is made beneficially own at least the Requisite Percentage as of the date on which such
request is delivered to the Secretary. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii)&nbsp;&nbsp;&nbsp;&nbsp;The Corporation may require the requesting
stockholder(s) to furnish such other information as may be reasonably requested by the Corporation. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv)&nbsp;&nbsp;&nbsp;&nbsp;The Corporation will provide the requesting stockholder(s) with notice of the record date for the
determination of stockholders entitled to vote at the Stockholder Requested Special Meeting. Each requesting stockholder is required to update the notice delivered pursuant to this Section&nbsp;1.2 not later than ten (10)&nbsp;business days after
such record date to provide any material changes in the foregoing information as of such record date. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v)&nbsp;&nbsp;&nbsp;&nbsp;In determining whether a Stockholder Requested Special Meeting has been requested by the record
holders of shares representing in the aggregate at least the Requisite Percent, multiple Special Meeting Requests delivered to the Secretary will be considered together only if each such Special Meeting Request (x)&nbsp;identifies substantially the
same purpose or purposes of the special meeting and substantially the same matters proposed to be acted on at the special meeting (in each case as determined in good faith by the Board), and (y)&nbsp;has been dated and delivered to the Secretary
within sixty (60)&nbsp;days of the earliest dated of such Special Meeting Requests. If the record holder is not the signatory to the Special Meeting Request, such Special Meeting Request will not be valid unless documentary evidence is supplied to
the Secretary at the time of delivery of such Special Meeting Request (or within ten (10)&nbsp;business days thereafter) of such signatory&#146;s authority to execute the Special Meeting Request on behalf of the record holder. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(vi)&nbsp;&nbsp;&nbsp;&nbsp;Any requesting stockholder may revoke his, her or its Special Meeting Request at any time by
written revocation delivered to the Secretary at the principal executive offices of the Corporation; provided, however, that if at any time following such revocation (including any revocation resulting from a disposition of shares), the unrevoked
valid Special Meeting Requests represent in the aggregate less than the Requisite Percent, there shall be no requirement to hold a special meeting. The first date on which unrevoked valid Special Meeting Requests constituting not less than the
Requisite Percentage shall have been delivered to the Corporation is referred to herein as the &#147;Request Receipt Date&#148;. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-3- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(vii)&nbsp;&nbsp;&nbsp;&nbsp;A Special Meeting Request shall not be valid
if: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A)&nbsp;&nbsp;&nbsp;&nbsp;the Special Meeting Request relates to an item of business that is not a proper subject for
stockholder action under applicable law; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B)&nbsp;&nbsp;&nbsp;&nbsp;the Request Receipt Date is during the period
commencing ninety (90)&nbsp;days prior to the first anniversary of the date of the immediately preceding annual meeting and ending on the date of the next annual meeting; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(C)&nbsp;&nbsp;&nbsp;&nbsp;the purpose specified in the Special Meeting Request is not the election of directors and an
identical or substantially similar item (as determined in good faith by the Board, a &#147;Similar Item&#148;) was presented at any meeting of stockholders held within the twelve (12)&nbsp;months prior to the Request Receipt Date; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(D)&nbsp;&nbsp;&nbsp;&nbsp;a Similar Item consisting of the election or removal of directors was presented at a meeting of
stockholders held not more than ninety (90)&nbsp;days before the Special Meeting Request was delivered to the Corporation (and, for purposes of this clause, the election or removal of directors shall be deemed a &#147;Similar Item&#148; with respect
to all items of business involving the election or removal of directors, changing the size of the Board and the filling of vacancies and/or newly created directorships resulting from any increase in the authorized number of directors; or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(E)&nbsp;&nbsp;&nbsp;&nbsp;a Similar Item is included in the Corporation&#146;s notice as an item of business to be brought
before an annual or special meeting of stockholders that has been called but not yet held or that is called for a date within ninety (90)&nbsp;days of the Request Receipt Date. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(viii)&nbsp;&nbsp;&nbsp;&nbsp;A Stockholder Requested Special Meeting shall be held at such date and time as may be fixed by
the Board; provided, however, that the Stockholder Requested Special Meeting shall be called for a date not more than ninety (90)&nbsp;days after the Request Receipt Date. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ix)&nbsp;&nbsp;&nbsp;&nbsp;Business transacted at any Stockholder Requested Special Meeting shall be limited to (i)&nbsp;the
purpose(s) stated in the valid Special Meeting Request(s) received from the Requisite Percentage of record holders and (ii)&nbsp;any additional matters that the Board determines to include in the Corporation&#146;s notice of the meeting. If none of
the stockholders who submitted the Special Meeting Request appears or sends a qualified representative to present the matters to be presented for consideration that were specified in the Stockholder Meeting Request, the Corporation need not present
such matters for a vote at such meeting, notwithstanding that proxies in respect of such matter may have been received by the Corporation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.3.&nbsp;&nbsp;&nbsp;&nbsp;<U>Notice of Meetings</U>. Notice of each meeting of stockholders shall be given stating the place,
date and hour of the meeting, the means of remote communications, if any, by which stockholders and proxyholders may be deemed to be present in person and vote at such meeting, the record date for determining the stockholders entitled to vote at the
meeting, if such date is different from the record date for determining stockholders entitled to notice of the meeting, and, in the case of a special meeting, the purpose or purposes for which the meeting is called. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-4- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise provided by law, the written notice of any meeting shall be given not less
than ten nor more than sixty days before the date of the meeting to each stockholder entitled to vote at such meeting as of the record date for determining the stockholders entitled to notice of the meeting. If mailed, such notice shall be deemed to
be given when deposited in the United States mail, postage prepaid, directed to the stockholder at such stockholder&#146;s address as it appears on the records of the Corporation. In addition, if given by electronic mail, then such notice by
electronic mail shall be deemed to be given when directed to such stockholder&#146;s electronic mail address (unless the stockholder has notified the Corporation in writing or by electronic transmission of an objection to receiving notice by
electronic mail or such notice is prohibited by the Delaware General Corporation Law to be given by electronic transmission). If such notice is transmitted by a posting on an electronic network together with separate notice to the stockholder of
such specific posting, such notice shall be deemed to be given upon the later of (i)&nbsp;such posting, and (ii)&nbsp;the giving of such separate notice. If such notice is transmitted by any other form of electronic transmission, such notice shall
be deemed to be given when directed to the stockholder. Notice shall be deemed to have been given to all stockholders of record who share an address if notice is given in accordance with the &#147;householding&#148; rules set forth in the rules of
the Securities and Exchange Commission under the Securities Exchange Act of 1934 (the &#147;Exchange Act&#148;) and Section&nbsp;233 of the Delaware General Corporation Law. For purposes of these <FONT STYLE="white-space:nowrap">by-laws,</FONT>
&#147;electronic transmission&#148; means any form of communication, not directly involving the physical transmission of paper, including the use of, or participation in, one or more electronic networks or databases (including one or more
distributed electronic networks or databases), that creates a record that may be retained, retrieved and reviewed by a recipient thereof, and that may be directly reproduced in paper form through an automated process. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.4.&nbsp;&nbsp;&nbsp;&nbsp;<U>Adjournments</U>. When a meeting of stockholders is adjourned to another time or place, it shall
not be necessary to give any notice of any such adjourned meeting if the time, place, if any, thereof, and the means of remote communications, if any, thereof are announced at the meeting at which the adjournment is taken, and at the adjourned
meeting any business may be transacted that might have been transacted on the original date of the meeting. However, if the adjournment is for more than thirty days, or if after the adjournment the Board fixes a new record date for determining the
stockholders entitled to vote at the adjourned meeting, a notice of the adjourned meeting shall be given to each stockholder of record as of the new record date for determining the stockholders entitled to notice of the adjourned meeting under
Section&nbsp;1.3. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.5.&nbsp;&nbsp;&nbsp;&nbsp;<U>Waiver of Notice</U>. Notice of meeting need not be given to any
stockholder who submits a signed waiver of notice, in person or by proxy, or a waiver by electronic transmission, whether before or after the meeting. The attendance of any stockholder at a meeting, in person or by proxy, except when the person
attends a meeting for the express purpose of objecting, at the beginning of the meeting, to the transaction of any business because the meeting is not lawfully called or convened, shall constitute a waiver of notice by such stockholder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.6.&nbsp;&nbsp;&nbsp;&nbsp;<U>Inspectors</U>. Prior to any meeting of stockholders, the Board or the President shall appoint one
or more inspectors to act at such meeting and make a written report thereof and may designate one or more persons as alternate inspectors to replace any inspector who fails to act. If no inspector or alternate is able to act at the meeting of
stockholders, the person presiding at the meeting shall appoint one or more inspectors to act at the meeting. Each inspector, before entering upon the discharge of his or her duties, shall take and sign an oath faithfully to execute
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-5- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the duties of inspector with strict impartiality and according to the best of his or her ability. The inspectors shall ascertain the number of shares outstanding and the voting power of each,
determine the shares represented at the meeting and the validity of proxies and ballots, count all votes and ballots, determine and retain for a reasonable period a record of the disposition of any challenges made to any determination by the
inspectors and certify their determination of the number of shares represented at the meeting and their count of all votes and ballots. The inspectors may appoint or retain other persons to assist them in the performance of their duties. The date
and time of the opening and closing of the polls for each matter upon which the stockholders will vote at a meeting shall be announced at the meeting. No ballot, proxy or vote, nor any revocation thereof or change thereto, shall be accepted by the
inspectors after the closing of the polls. In determining the validity and counting of proxies and ballots, the inspectors shall be limited to an examination of the proxies, any envelopes submitted therewith, any information provided by a
stockholder who submits a proxy by electronic transmission from which it can be determined that the proxy was authorized by the stockholder, any written ballot or, if authorized by the Board, a ballot submitted by electronic transmission together
with any information from which it can be determined that the electronic transmission was authorized by the stockholder, any information provided in a record of a vote if such vote was taken at the meeting by means of remote communication along with
any information used to verify that any person deemed present and permitted to vote at the meeting by means of remote communication is a stockholder, ballots and the regular books and records of the corporation, and they may also consider other
reliable information for the limited purpose of reconciling proxies and ballots submitted by or on behalf of banks, brokers, their nominees or similar persons which represent more votes than the holder of a proxy is authorized by the record owner to
cast or more votes than the stockholder holds of record. If the inspectors consider other reliable information for such purpose, they shall, at the time they make their certification, specify the precise information considered by them, including the
person or persons from whom they obtained the information, when the information was obtained, the means by which the information was obtained and the basis for the inspectors&#146; belief that such information is accurate and reliable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.7.&nbsp;&nbsp;&nbsp;&nbsp;<U>List of Stockholders at Meetings</U>. The Secretary shall prepare and make, at least ten days
before every meeting of stockholders, a complete list of the stockholders entitled to vote at the meeting; provided, however, if the record date for determining the stockholders entitled to vote is less than ten days before the meeting date, the
list shall reflect the stockholders entitled to vote as of the tenth day before the meeting date, arranged in alphabetical order, and showing the address of each stockholder and the number of shares registered in the name of each stockholder.
Nothing in this Section shall require the Corporation to include electronic mail addresses or other electronic content information on such list. Such list shall be open to the examination of any stockholder for any purpose germane to the meeting for
a period of at least ten days prior to the meeting: (i)&nbsp;on a reasonably accessible electronic network, provided that the information required to gain access to such list is provided with the notice of the meeting, or (ii)&nbsp;during ordinary
business hours, at the principal executive offices of the Corporation. In the event that the Corporation determines to make the list available on an electronic network, the Corporation may take reasonable steps to ensure that such information is
available only to stockholders of the Corporation. If the meeting is to be held at a place, then a list of stockholders entitled to vote at the meeting shall be produced and kept at the time and place of the meeting during the whole time thereof and
may be examined by any stockholder who is present. If the meeting is to be held solely by means of remote communication, then such list shall also be open </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-6- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
to the examination of any stockholder during the whole time of the meeting on a reasonably accessible electronic network, and the information required to access such list shall be provided with
the notice of the meeting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.8.&nbsp;&nbsp;&nbsp;&nbsp;<U>Quorum of Stockholders</U>. The holders of a majority of the
shares of stock entitled to vote on a matter at a meeting of stockholders, present in person or represented by proxy, shall constitute a quorum at such meeting of stockholders for the transaction of any business, provided that when a specified item
of business is required to be voted on by a class or series, voting as a class or series, the holders of a majority of the shares of such class or series shall constitute a quorum for the transaction of such specified items of business. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">When a quorum is once present to organize a meeting, it is not broken by the subsequent withdrawal of any stockholders. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the absence of a quorum, the stockholders present in person or represented by proxy and entitled to vote may, by a majority of the votes
cast, adjourn the meeting in the manner provided by Section&nbsp;1.4 of these <FONT STYLE="white-space:nowrap">by-laws</FONT> until a quorum is so present or represented or (ii)&nbsp;the Chairperson of the meeting may on his or her own motion
adjourn the meeting in the manner provided by Section&nbsp;1.4 of these <FONT STYLE="white-space:nowrap">by-laws</FONT> until a quorum is so present and represented without the approval of the stockholders who are present in person or represented by
proxy and entitled to vote, without notice other than announcement at the meeting, despite the absence of a quorum. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.9.&nbsp;&nbsp;&nbsp;&nbsp;<U>Voting; Proxies</U>. Directors shall, except as otherwise required by law or by the certificate of
incorporation, be elected by a plurality of the votes cast at a meeting of the stockholders by the holders of shares entitled to vote in the election. Whenever any corporate action, other than the election of directors, is to be taken by vote of the
stockholders, it shall, unless a different or minimum vote is required by law or by the certificate of incorporation, these <FONT STYLE="white-space:nowrap">by-laws,</FONT> the rules or regulations of any stock exchange applicable to the
Corporation, or any law or regulation applicable to the Corporation or its securities, in which case such different or minimum vote shall be the applicable vote on the matter, be authorized by a majority of the votes cast at the meeting of
stockholders by the holders of shares entitled to vote thereon </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Every stockholder entitled to vote at a meeting of stockholders or to
express consent or dissent without a meeting may authorize another person or persons to act for him or her by proxy. Every proxy must be signed by the stockholder or his authorized officer, director, employee or agent or provided by electronic
transmission in accordance with applicable law. No proxy shall be valid after the expiration of three years from the date thereof unless otherwise provided in the proxy. A duly executed proxy shall be irrevocable if it states that it is irrevocable
and if, and only as long as, it is coupled with an interest sufficient in law to support an irrevocable power, regardless of whether the interest with which it is coupled is an interest in the stock itself or an interest in the Corporation
generally. A stockholder may revoke any proxy which is not irrevocable by attending the meeting and voting in person or by filing an instrument in writing revoking the proxy or another duly executed proxy bearing a later date with the Secretary.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The authority of the holder of a proxy to act shall not be revoked by the incompetence or death of the stockholder who executed the
proxy, unless, before the authority is exercised, written notice of an adjudication of such incompetence or of such death is received by the Secretary or any Assistant Secretary. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-7- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.10.&nbsp;&nbsp;&nbsp;&nbsp;<U>Consent of Stockholders in Lieu of Meeting</U>.
Any action required or permitted to be taken by the stockholders of the Corporation may be effected by a consent or consents in writing by the stockholders in accordance with, and subject to the limitations set forth in, the certificate of
incorporation. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.11.&nbsp;&nbsp;&nbsp;&nbsp;<U>Fixing Record Date</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;In order that the Corporation may determine the stockholders entitled to notice of any meeting of stockholders or
any adjournment thereof, the Board may fix a record date, which record date shall not precede the date upon which the resolution fixing the record date is adopted by the Board, and which record date shall not be more than sixty nor less than ten
days before the date of such meeting. If the Board so fixes a date, such date shall also be the record date for determining the stockholders entitled to vote at such meeting unless the Board determines, at the time it fixes such record date, that a
later date on or before the date of the meeting shall be the date for making such determination. If no record date is fixed by the Board, the record date for determining stockholders entitled to notice of and to vote at a meeting of stockholders
shall be at the close of business on the day next preceding the day on which notice is given, or, if notice is waived, at the close of business on the day next preceding the day on which the meeting is held. A determination of stockholders of record
entitled to notice of or to vote at a meeting of stockholders shall apply to any adjournment of the meeting; provided, however, that the Board may fix a new record date for determination of stockholders entitled to vote at the adjourned meeting, and
in such case shall also fix the record date for stockholders entitled to notice of such adjourned meeting the same or an earlier date as that fixed for determination of stockholders entitled to vote in accordance with the foregoing provisions of
this Section&nbsp;1.11 at the adjourned meeting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;In order that the Corporation may determine the stockholders
entitled to consent to any corporate action in writing without a meeting, the Board may fix a record date, which record date shall not precede the date upon which the resolution fixing the record date is adopted by the Board, and which record date
shall not be more than ten (10)&nbsp;days after the date on which the resolution fixing the record date is adopted by the Board. If no record date has been fixed by the Board, the record date for determining stockholders entitled to consent to
corporate action in writing without a meeting, when no prior action by the Board is required by law, shall be the first date on which a signed written consent setting forth the action taken or proposed to be taken is delivered to the Corporation by
delivery to its registered office in the State of Delaware or its principal place of business. Delivery shall be by hand or by certified or registered mail, return receipt requested. If no record date has been fixed by the Board and prior action by
the Board is required by law, the record date for determining stockholders entitled to consent to corporate action in writing without a meeting shall be the day on which the Board adopts the resolution taking such prior action. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-8- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;In order that the Corporation may determine the stockholders
entitled to receive payment of any dividend or other distribution or allotment of any rights or the stockholders entitled to exercise any rights in respect of any change, conversion or exchange of stock, or for the purpose of any other lawful
action, the Board may fix a record date, which record date shall not precede the date upon which the resolution fixing the record date is adopted, and which record date shall be not more than sixty days prior to such action. If no record date is
fixed, the record date for determining stockholders for any such purpose shall be at the close of business on the day on which the Board adopts the resolution relating thereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.12.&nbsp;&nbsp;&nbsp;&nbsp;<U>Organization</U>. Meetings of the Board shall be presided over by the Chairperson of the Board,
if any, or in the absence of the Chairperson of the Board by the Vice Chairperson of the Board, if any, or in the absence of the Vice Chairperson of the Board by the President, or in their absence by a chairperson chosen at the meeting. The
Secretary, or in the absence of the Secretary an Assistant Secretary, shall act as secretary of the meeting, but in the absence of the Secretary and any Assistant Secretary the chairperson of the meeting may appoint any person to act as secretary of
the meeting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The order of business at each such meeting shall be as determined by the chairperson of the meeting. The chairperson of the
meeting shall have the right and authority to prescribe such rules, regulations and procedures and to do all such acts and things as are necessary or desirable for the proper conduct of the meeting, including, without limitation, the establishment
of procedures for the maintenance of order and safety, limitations on the time allotted to questions or comments on the affairs of the Corporation, restrictions on entry to such meeting after the time prescribed for the commencement thereof and the
opening and closing of the voting polls, for each item on which a vote is to be taken. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.13.&nbsp;&nbsp;&nbsp;&nbsp;<U>Advance Notice of Stockholder Nominees for Director and Other Stockholder Proposals</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;No business shall be transacted at an annual or special meeting of stockholders, except such business as shall be
properly brought before such meeting in compliance with the procedures set forth in this Section&nbsp;1.13. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;For any matter to be properly brought before an annual meeting of stockholders, the matter must be
(i)&nbsp;specified in the Corporation&#146;s notice of meeting as provided in Section&nbsp;1.3 of these <FONT STYLE="white-space:nowrap">by-laws,</FONT> (ii)&nbsp;otherwise brought before the meeting by or at the direction of the Board, or
(iii)&nbsp;otherwise brought before the meeting by a stockholder of record of the Corporation entitled to vote at the meeting in compliance with the procedure set forth in this Section&nbsp;1.13. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;In addition to any other requirements under applicable law and the certificate of incorporation and
these <FONT STYLE="white-space:nowrap">by-laws</FONT> of the Corporation, for any matter to be brought properly before an annual meeting by a stockholder pursuant to subsection (iii)&nbsp;above, written notice by the stockholder (the
&#147;Stockholder Notice&#148;) of any director nomination or other proposal must be addressed and delivered to the Corporation, or mailed to the Corporation, postage prepaid, and received, at the principal executive office of the Corporation not
less than sixty (60)&nbsp;days nor more than ninety (90)&nbsp;days prior to the first anniversary date of the annual meeting for the preceding year (which shall include for all purposes hereunder, in the case of the first annual meeting of
stockholders following the merger of CONMED Corporation, a New York corporation (the &#147;New York Corporation&#148;), with and into the Corporation, the first anniversary of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-9- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
the annual meeting of the New York Corporation&#146;s shareholders for the preceding year); ; provided, however, that if (and only if) the annual meeting is not scheduled to be held within a
period that commences thirty (30)&nbsp;days before such anniversary date and ends within thirty (30)&nbsp;days after such anniversary date (an annual meeting date outside such period being referred to herein as an &#147;Other Meeting Date&#148;),
the Stockholder Notice shall be given in the manner provided herein by the later of the close of business on (i)&nbsp;the date ninety (90)&nbsp;days prior to such Other Meeting Date or (ii)&nbsp;the tenth (10th) day following the date such Other
Meeting Date is first publicly announced or disclosed. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii)&nbsp;&nbsp;&nbsp;&nbsp;The Stockholder Notice must set forth
in writing: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A)&nbsp;&nbsp;&nbsp;&nbsp;as to the stockholder giving the notice and the beneficial owner, if any, on whose
behalf the nomination or proposal is made: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) &nbsp;&nbsp;&nbsp;&nbsp;the name and address of such stockholder as they
appear in the Corporation&#146;s books, and of such beneficial owner, if any; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) &nbsp;&nbsp;&nbsp;&nbsp;(i) the class
or series and number of shares of the Corporation which are, directly or indirectly, owned of record and/or owned beneficially by the stockholder and such beneficial owner, if any, and a representation that the stockholder and beneficial owner, if
any, will notify the Corporation in writing of the class or series and number of such shares owned of record and beneficially as of the record date for the meeting, promptly following the later of the record date and the date notice of the record
date is first publicly announced; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:18%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) any option, warrant, convertible security, stock appreciation right, or similar
right with an exercise or conversion privilege or a settlement payment or mechanism at a price related to any class or series of shares of the Corporation or with a value derived in whole or in part from the value of any class or series of shares of
the Corporation, whether or not such instrument or right shall be subject to settlement in the underlying class or series of capital stock of the Corporation or otherwise (a &#147;Derivative Instrument&#148;) directly or indirectly owned
beneficially by such stockholder and beneficial owner, if any, and any other direct or indirect opportunity to profit or share in any profit derived from any increase or decrease in the value of shares of the Corporation; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:18%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) any proxy, contract, arrangement, understanding or relationship pursuant to which such stockholder and beneficial owner,
if any, has a right to vote any shares of any security of the Corporation; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:18%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) any short interest in any security of the
Corporation (for purposes hereof, a person or entity shall be deemed to have a short interest in a security if such person or entity directly or indirectly, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-10- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:18%; font-size:10pt; font-family:Times New Roman">
through any contract, arrangement, understanding, relationship or otherwise, has the opportunity to profit or share in any profit derived from any decrease in the value of the subject security);
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:18%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v) any rights to dividends on the shares of the Corporation owned beneficially by such stockholder and beneficial owner,
if any, that are separated or separable from the underlying shares of the Corporation; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:18%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(vi) any proportionate interest in
shares of the Corporation or Derivative Instruments held, directly or indirectly, by a general or limited partnership in which such stockholder and beneficial owner, if any, is a general partner or, directly or indirectly, beneficially owns an
interest in a general partner; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:18%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(vii) any performance-related fees (other than an asset-based fee) that such
stockholder and beneficial owner, if any, is entitled to based on any increase or decrease in the value of shares of the Corporation or Derivative Instruments, if any, as of the date of such notice, including without limitation any such interests
held by such stockholder&#146;s and beneficial owner&#146;s, if any, affiliates, any person or entity with whom such stockholder and beneficial owner, if any, is acting in concert or members of such stockholder&#146;s and beneficial owner&#146;s, if
any, immediate family sharing the same household; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) &nbsp;&nbsp;&nbsp;&nbsp;any other information relating to such
stockholder and beneficial owner, if any, that would be required to be disclosed in a proxy statement or other filings required to be made in connection with solicitations of proxies for, as applicable, the proposal and/or for the election of
directors in a contested election pursuant to Section&nbsp;14 of the Exchange Act and the rules and regulations promulgated thereunder; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4)&nbsp;&nbsp;&nbsp;&nbsp; a representation that the stockholder is a holder of record of stock of the Corporation entitled
to vote at such annual meeting on the matter proposed and intends to appear in person or by proxy at such meeting to propose such nomination or other business; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(5) &nbsp;&nbsp;&nbsp;&nbsp;if the stockholder intends to solicit proxies in support of such stockholder&#146;s proposal, a
representation to that effect. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B)&nbsp;&nbsp;&nbsp;&nbsp;if the notice relates to any business that the stockholder
proposes to bring before the meeting other than a nomination of a director or directors: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) &nbsp;&nbsp;&nbsp;&nbsp;a
brief description of the business desired to be brought before the meeting, the text of the proposal or business (including the text of any resolutions proposed for consideration), the reasons for conducting such business at the meeting, any
material interest of such stockholder and beneficial owner, if any, on whose behalf the business is being proposed and of each of their respective affiliates or associates or others acting in concert therewith, if any, in such business and, in the
event that such business includes a proposal to amend the <FONT STYLE="white-space:nowrap">by-</FONT> laws of the Corporation, the language of the proposed amendment; and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-11- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) &nbsp;&nbsp;&nbsp;&nbsp;a description of all agreements, arrangements
and understandings between such stockholder and/or beneficial owner, if any, and any other person or persons (including the names of such persons) in connection with the proposal of such business by such stockholder. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(C)&nbsp;&nbsp;&nbsp;&nbsp;If the stockholder proposes to nominate a person for election or reelection to the Board: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1)&nbsp;&nbsp;&nbsp;&nbsp; as to each person whom the stockholder proposes to nominate for election or reelection to the
Board: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:18%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;all information relating to such person that would be required to be disclosed in a
proxy statement or other filings required to be made in connection with solicitations of proxies for the election of directors in a contested election pursuant to Section&nbsp;14 of the Exchange Act and the rules and regulations promulgated
thereunder including such person&#146;s written consent to being named in the proxy statement as a nominee and to serving as a director if elected); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:18%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii)&nbsp;&nbsp;&nbsp;&nbsp;a description of all direct and indirect compensation and other material monetary agreements,
arrangements and understandings during the past three (3)&nbsp;years, and any other material relationships, between or among such stockholder and beneficial owner, if any, and their respective affiliates and associates, or others acting in concert
therewith, on the one hand, and each proposed nominee, and his or her respective affiliates and associates, or others acting in concert therewith, on the other hand, including without limitation all information that would be required to be disclosed
pursuant to Rule 404 promulgated by the Securities and Exchange Commission under Regulation <FONT STYLE="white-space:nowrap">S-K</FONT> (or any successor rule or regulation) if the stockholder making the nomination and any beneficial owner on whose
behalf the nomination is made, if any, or any affiliate or associate thereof or person acting in concert therewith, were the &#147;registrant&#148; for purposes of such rule and the nominee were a director or executive officer of such
&#147;registrant&#148;; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:18%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) &nbsp;&nbsp;&nbsp;&nbsp;such other information as may be necessary to enable the Board
to make an informed determination as to whether such nominee, if elected, would be an &#147;independent director&#148; as defined in the rules and regulations of the New York Stock Exchange or any other stock exchange on which the Corporation&#146;s
Common Stock is listed or quoted, or that could be material to a reasonable stockholder&#146;s understanding of the independence, or lack thereof, of such nominee. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-12- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) &nbsp;&nbsp;&nbsp;&nbsp;the details of any relationship that existed
within the past three years and that would have been described pursuant to Item 6(e) of Schedule 14N (or any successor item) if it existed on the date of submission of the Schedule 14N; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) &nbsp;&nbsp;&nbsp;&nbsp;a representation and warranty that the candidacy or, if elected, Board membership of each person
whom the stockholder proposes to nominate for election or reelection to the Board would not violate applicable state or federal law or the rules of any stock exchange on which the Corporation&#146;s securities are traded; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4) &nbsp;&nbsp;&nbsp;&nbsp;a representation and warranty that each person whom the stockholder proposes to nominate for
election or reelection to the Board: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:18%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) &nbsp;&nbsp;&nbsp;&nbsp;does not have any direct or indirect relationship with
the Corporation that would cause such person to be considered not independent pursuant to the Corporation&#146;s Corporate Governance Guidelines as most recently published on its website and otherwise qualifies as independent under the rules of the
primary stock exchange on which the Corporation&#146;s shares of common stock are traded; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:18%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii)
&nbsp;&nbsp;&nbsp;&nbsp;meets the audit committee and compensation committee independence requirements under the rules of the primary stock exchange on which the Corporation&#146;s shares of common stock are traded; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:18%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii)&nbsp;&nbsp;&nbsp;&nbsp; is a <FONT STYLE="white-space:nowrap">&#147;non-employee</FONT> director&#148; for the purposes
of Rule <FONT STYLE="white-space:nowrap">16b-3</FONT> under the Exchange Act (or any successor rule); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:18%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv)
&nbsp;&nbsp;&nbsp;&nbsp;is an &#147;outside director&#148; for the purposes of Section&nbsp;162(m) of the Internal Revenue Code (or any successor provision); and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:18%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v)&nbsp;&nbsp;&nbsp;&nbsp; is not and has not been subject to any event specified in Rule 506(d)(1) of Regulation D (or any
successor rule) under the Securities Act of 1933 or Item 401(f) of Regulation <FONT STYLE="white-space:nowrap">S-K</FONT> (or any successor rule) under the Exchange Act, without reference to whether the event is material to an evaluation of the
ability or integrity of such person; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-13- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(5)&nbsp;&nbsp;&nbsp;&nbsp;details of any position where each person whom
the stockholder proposes to nominate for election or reelection to the Board has served as an officer or director of any competitor (that is, any entity that produces products, provides services or engages in business activities that compete with or
are alternatives to the products produced, services provided or business activities engaged in by the Corporation or its affiliates) of the Corporation, within the three years preceding the submission of the Stockholder Notice; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(D) &nbsp;&nbsp;&nbsp;&nbsp;The Corporation may also require any proposed nominee to furnish such other information, including
completion of the Corporation&#146;s directors questionnaire, as it may reasonably request. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;For any matter to
be properly brought before a special meeting of stockholders, the matter must be set forth in the Corporation&#146;s notice of such meeting given by or at the direction of the Board or by the Secretary of the Corporation pursuant to
Section&nbsp;1.2(b) of these <FONT STYLE="white-space:nowrap">by-laws.</FONT> In the event the Corporation calls a special meeting of stockholders for the purpose of electing one or more directors to the Board, any stockholder entitled to vote for
the election of such director(s) at such meeting may nominate a person or persons (as the case may be) for election to such position(s) as specified in the Corporation&#146;s notice of such meeting, but only if a Stockholder&#146;s Notice containing
the information required by subsection (b)&nbsp;of this Section&nbsp;1.13 shall be delivered to the Secretary at the principal executive offices of the Corporation not later than the close of business on the tenth (10th) day following the day on
which public announcement is first made of the date of the special meeting and of the nominees proposed by the Board to be elected at such meeting </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;For purposes of this Section&nbsp;1.13, a matter shall be deemed to have been &#147;publicly announced or
disclosed&#148; if such matter is disclosed in a press release issued by the Corporation and distributed by a national news service or in a document publicly filed by the Corporation with the Securities and Exchange Commission. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;For purposes of this Section&nbsp;1.13, (i) &#147;affiliate&#148; and &#147;associate&#148; have the meanings
ascribed thereto in Rule 405 under the Securities Act of 1933, as amended; provided, however, that the term &#147;partner&#148; as used in the definition of &#147;associate&#148; shall not include any limited partner that is not involved in the
management of the relevant partnership, and (ii)&nbsp;&#147;beneficially owned&#148; has the meaning ascribed thereto in Rules <FONT STYLE="white-space:nowrap">13d-3</FONT> and <FONT STYLE="white-space:nowrap">13d-5</FONT> under the Exchange Act.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f)&nbsp;&nbsp;&nbsp;&nbsp;In no event shall the postponement or adjournment of an annual or special meeting (whether or not already
publicly noticed), or any announcement of such postponement or adjournment, commence a new period (or extend any time period) for the giving of notice as provided in this Section&nbsp;1.13. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g)&nbsp;&nbsp;&nbsp;&nbsp;This Section&nbsp;1.13 shall not apply to (i)&nbsp;any stockholder proposal made pursuant to Rule <FONT
STYLE="white-space:nowrap">14a-8</FONT> of the Exchange Act, (ii)&nbsp;any director nomination pursuant to Section&nbsp;1.14 or (iii)&nbsp;any Stockholder Requested Special Meeting (except as specifically provided in Section&nbsp;1.13(c)). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-14- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h)&nbsp;&nbsp;&nbsp;&nbsp;The Chair of any meeting of stockholders shall, if the facts
warrant, determine and declare to the meeting that any business was not properly brought before the meeting in accordance with the provisions prescribed by these <FONT STYLE="white-space:nowrap">by-laws</FONT> and, if he or she should so determine,
he or she shall so declare to the meeting and, to the extent permitted by law, any such business not so properly brought before the meeting shall not be transacted; provided that nothing herein shall prevent the Board or any duly authorized
committee thereof from making such determinations in advance of any meeting of stockholders. Notwithstanding the foregoing provisions of this Section&nbsp;1.13, if the stockholder or a qualified representative of the stockholder does not appear at
the annual meeting of stockholders of the Corporation to present any such nomination, or make any such proposal, such nomination or proposal shall be disregarded, notwithstanding that proxies in respect of such vote may have been received by the
Corporation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;Nothing in this Section&nbsp;1.13 shall be deemed to affect any right of a stockholder to request
inclusion of a proposal in, nor the right of the Corporation to omit a proposal from, the Corporation&#146;s proxy statement pursuant to Rule <FONT STYLE="white-space:nowrap">14a-8</FONT> under the Exchange Act. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.14.&nbsp;&nbsp;&nbsp;&nbsp;<U>Proxy Access for Stockholder Nominations of Directors</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;<U>Inclusion of Nominees in Proxy Statement</U>. Subject to the provisions of this Section&nbsp;1.14, if expressly
requested in the relevant Proxy Access Notice (as defined below), the Corporation shall include in its proxy statement for any annual meeting of stockholders: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;the names of any person or persons nominated for election (each, a &#147;Nominee&#148;), which shall
also be included on the Corporation&#146;s form of proxy and ballot, by any Eligible Holder (as defined below) or group of up to twenty Eligible Holders that has (individually and collectively, in the case of a group) satisfied, as determined by the
Board, all applicable conditions and complied with all applicable procedures set forth in this Section&nbsp;1.14 (such Eligible Holder or group of Eligible Holders being a &#147;Nominating Stockholder&#148;); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii)&nbsp;&nbsp;&nbsp;&nbsp;disclosure about each Nominee and the Nominating Stockholder required under the rules of the SEC or
other applicable law to be included in the proxy statement; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii)&nbsp;&nbsp;&nbsp;&nbsp;any statement included by the
Nominating Stockholder in the Proxy Access Notice for inclusion in the proxy statement in support of each Nominee&#146;s election to the Board (subject, without limitation, to Section&nbsp;1.14(e)(ii)), if such statement does not exceed 500 words
and fully complies with Section&nbsp;14 of the Exchange Act and the rules and regulations thereunder, including Rule <FONT STYLE="white-space:nowrap">14a-9</FONT> (the &#147;Supporting Statement&#148;); and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv)&nbsp;&nbsp;&nbsp;&nbsp;any other information that the Corporation or the Board determines, in their discretion, to include
in the proxy statement relating to the nomination of each Nominee, including, without limitation, any statement in opposition to the nomination, any of the information provided pursuant to this Section&nbsp;1.14 and any solicitation materials or
related information with respect to a Nominee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For purposes of this Section&nbsp;1.14, any determination to be made by the Board may be
made by the Board, a committee of the Board or any officer of the Corporation designated by the Board or a committee of the Board, and any such determination shall be final and binding on the Corporation, any Eligible Holder, any Nominating
Stockholder, any Nominee and any other person so long as made in good faith (without any further requirements). The Chair of any annual meeting of stockholders, in addition to making any other determinations that may be appropriate to the conduct of
the meeting, shall have the power and duty to determine whether a Nominee has been nominated in accordance with the requirements of this Section&nbsp;1.14 and, if not so nominated, shall direct and declare at the meeting that such Nominee shall not
be considered. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-15- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;<U>Maximum Number of Nominees</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;The Corporation shall not be required to include in the proxy statement for an annual meeting of
stockholders more Nominees than that number of directors constituting the greater of (i)&nbsp;two or (ii) 20% of the total number of directors of the Corporation on the last day on which a Proxy Access Notice may be submitted pursuant to this
Section&nbsp;1.14 (rounded down to the nearest whole number) (the &#147;Maximum Number&#148;). The Maximum Number for a particular annual meeting shall be reduced by: (1)&nbsp;Nominees who the Board itself decides to nominate for election at such
annual meeting; (2)&nbsp;Nominees who cease to satisfy, or Nominees of Nominating Stockholders that cease to satisfy, the eligibility requirements in this Section&nbsp;1.14, as determined by the Board; (3)&nbsp;Nominees whose nomination is withdrawn
by the Nominating Stockholder or who become unwilling to serve on the Board; and (4)&nbsp;the number of incumbent directors who had been Nominees with respect to any of the preceding two annual meetings of stockholders and whose reelection at the
upcoming annual meeting is being recommended by the Board. In the event that one or more vacancies for any reason occurs on the Board after the deadline for submitting a Proxy Access Notice as set forth in Section&nbsp;1.14(d) below but before the
date of the annual meeting, and the Board resolves to reduce the size of the board in connection therewith, the Maximum Number shall be calculated based on the number of directors in office as so reduced. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii)&nbsp;&nbsp;&nbsp;&nbsp;If the number of Nominees pursuant to this Section&nbsp;1.14 for any annual meeting of stockholders
exceeds the Maximum Number then, promptly upon notice from the Corporation, each Nominating Stockholder will select one Nominee for inclusion in the proxy statement until the Maximum Number is reached, going in order of the amount (largest to
smallest) of the ownership position as disclosed in each Nominating Stockholder&#146;s Proxy Access Notice, with the process repeated if the Maximum Number is not reached after each Nominating Stockholder has selected one Nominee. If, after the
deadline for submitting a Proxy Access Notice as set forth in Section&nbsp;1.14(d), a Nominating Stockholder or a Nominee ceases to satisfy the eligibility requirements in this Section&nbsp;1.14, as determined by the Board, a Nominating Stockholder
withdraws its nomination or a Nominee becomes unwilling to serve on the Board, whether before or after the mailing or other distribution of the definitive proxy statement, then the nomination shall be disregarded, and the Corporation: (1)&nbsp;shall
not be required to include in its proxy statement or on any ballot or form of proxy the disregarded Nominee or any successor or replacement nominee proposed by the Nominating Stockholder or by any other Nominating Stockholder and (2)&nbsp;may
otherwise communicate to its stockholders, including without limitation by amending or supplementing its proxy statement or ballot or form of proxy, that a Nominee will not be included as a nominee in the proxy statement or on any ballot or form of
proxy and will not be voted on at the annual meeting. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-16- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;<U>Eligibility of Nominating Stockholder</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;An &#147;Eligible Holder&#148; is a person who has either (1)&nbsp;been a record holder of the
shares of common stock used to satisfy the eligibility requirements in this Section&nbsp;1.14(c) continuously for the three-year period specified in subsection (ii)&nbsp;below or (2)&nbsp;provides to the Secretary, within the time period referred to
in Section&nbsp;1.14(d), evidence of continuous ownership of such shares for such three-year period from one or more securities intermediaries in a form that the Board determines would be deemed acceptable for purposes of a shareholder proposal
under Rule <FONT STYLE="white-space:nowrap">14a-8(b)(2)</FONT> under the Exchange Act (or any successor rule). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii)&nbsp;&nbsp;&nbsp;&nbsp;An Eligible Holder or group of up to twenty Eligible Holders may submit a nomination in accordance
with this Section&nbsp;1.14 only if the person or group (in the aggregate) has continuously owned at least the Minimum Number (as defined below) of shares of the Corporation&#146;s common stock throughout the three-year period preceding and
including the date of submission of the Proxy Access Notice, and continues to own at least the Minimum Number through the date of the annual meeting. Two or more funds that are (x)&nbsp;under common management and investment control, (y)&nbsp;under
common management and funded primarily by a single employer or (z)&nbsp;a &#147;group of investment companies,&#148; as such term is defined in Section&nbsp;12(d)(1)(G)(ii) of the Investment Company Act of 1940, as amended, shall be treated as one
Eligible Holder if such Eligible Holder shall provide together with the Proxy Access Notice documentation reasonably satisfactory to the Corporation that demonstrates that the funds meet the criteria set forth in (x), (y) or (z)&nbsp;hereof. For the
avoidance of doubt, in the event of a nomination by a group of Eligible Holders, any and all requirements and obligations for an individual Eligible Holder that are set forth in this Section&nbsp;1.14, including the minimum holding period, shall
apply to each member of such group; provided, however, that the Minimum Number shall apply to the ownership of the group in the aggregate. Should any stockholder cease to satisfy the eligibility requirements in this Section&nbsp;1.14, as determined
by the Board, or withdraw from a group of Eligible Holders at any time prior to the annual meeting of stockholders, the group of Eligible Stockholders shall only be deemed to own the shares held by the remaining members of the group. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii)&nbsp;&nbsp;&nbsp;&nbsp;The &#147;Minimum Number&#148; of shares of the Corporation&#146;s common stock means 3% of the
number of outstanding shares of common stock as of the most recent date for which such amount is given in any filing by the Corporation with the SEC prior to the submission of the Proxy Access Notice. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv)&nbsp;&nbsp;&nbsp;&nbsp;For purposes of this Section&nbsp;1.14, an Eligible Holder &#147;owns&#148; only those outstanding
shares of the Corporation as to which the Eligible Holder possesses both: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A)&nbsp;&nbsp;&nbsp;&nbsp;the full voting and
investment rights pertaining to the shares; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B)&nbsp;&nbsp;&nbsp;&nbsp;the full economic interest in (including the
opportunity for profit and risk of loss on) such shares, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-17- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">provided that the number of shares calculated in accordance with clauses (A)&nbsp;and (B)
shall not include any shares: (1)&nbsp;purchased or sold by such Eligible Holder or any of its affiliates in any transaction that has not been settled or closed, (2)&nbsp;sold short by such Eligible Holder, (3)&nbsp;borrowed by such Eligible Holder
or any of its affiliates for any purpose or purchased by such Eligible Holder or any of its affiliates pursuant to an agreement to resell or subject to any other obligation to resell to another person, or (4)&nbsp;subject to any option, warrant,
forward contract, swap, contract of sale, other derivative or similar agreement entered into by such Eligible Holder or any of its affiliates, whether any such instrument or agreement is to be settled with shares or with cash based on the notional
amount or value of outstanding shares of the Corporation, in any such case which instrument or agreement has, or is intended to have, the purpose or effect of: (x)&nbsp;reducing in any manner, to any extent or at any time in the future, such
Eligible Holder&#146;s or any of its affiliates&#146; full right to vote or direct the voting of any such shares, and/or (y)&nbsp;hedging, offsetting, or altering to any degree, gain or loss arising from the full economic ownership of such shares by
such Eligible Holder or any of its affiliates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">An Eligible Holder &#147;owns&#148; shares held in the name of a nominee or other
intermediary so long as the Eligible Holder retains the right to instruct how the shares are voted with respect to the election of directors and possesses the full economic interest in the shares. An Eligible Holder&#146;s ownership of shares shall
be deemed to continue during any period in which the Eligible Holder has delegated any voting power by means of a proxy, power of attorney, or other similar instrument or arrangement that is revocable at any time by the Eligible Holder. An Eligible
Holder&#146;s ownership of shares shall be deemed to continue during any period in which the Eligible Holder has loaned such shares provided that the Eligible Holder has the power to recall such loaned shares on five business days&#146; notice, has
recalled such loaned shares as of the date of the Proxy Access Notice and continues to hold such shares through the date of the annual meeting. The terms &#147;owned,&#148; &#147;owning&#148; and other variations of the word &#147;own&#148; shall
have correlative meanings. Whether outstanding shares of the Corporation are &#147;owned&#148; for these purposes shall be determined by the Board. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v)&nbsp;&nbsp;&nbsp;&nbsp;No Eligible Holder shall be permitted to be in more than one group constituting a Nominating
Stockholder, and if any Eligible Holder appears as a member of more than one group, it shall be deemed to be a member of the group that has the largest ownership position as reflected in the Proxy Access Notice. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;<U>Proxy Access Notice</U>. To nominate a Nominee, the Nominating Stockholder must, no earlier than one hundred
fifty (150)&nbsp;calendar days and no later than one hundred twenty (120)&nbsp;calendar days before the anniversary of the date that the Corporation mailed its proxy statement for the prior year&#146;s annual meeting of stockholders, submit to the
Secretary at the principal executive office of the Corporation all of the following information and documents (collectively, the &#147;Proxy Access Notice&#148;); provided, however, that if (and only if) the annual meeting is not scheduled to be
held within a period that commences thirty (30)&nbsp;days before such anniversary date and ends thirty days after the anniversary of the prior year&#146;s meeting date (an annual meeting date outside such period being referred to herein as an
&#147;Other Meeting Date&#148;), the Proxy Access Notice shall be given in the manner provided herein by the later of the close of business on the date that is one hundred eighty days (180)&nbsp;prior to such Other Meeting Date or the tenth (10th)
day following the date such Other Meeting Date is first publicly announced or disclosed. For purposes of this Section&nbsp;1.14, a matter shall be deemed to have been &#147;publicly announced or disclosed&#148; if such matter is disclosed in a press
release issued by the Corporation and distributed by a national news service or in a document publicly filed by the Corporation with the Securities and Exchange Commission. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-18- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;A Schedule 14N (or any successor form) relating
to each Nominee, completed and filed with the SEC by the Nominating Stockholder as applicable, in accordance with SEC rules; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii)&nbsp;&nbsp;&nbsp;&nbsp;A written notice, in a form deemed satisfactory by the Board, of the nomination of each Nominee
that includes the following additional information, agreements, representations and warranties by the Nominating Stockholder (including each group member): </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A)&nbsp;&nbsp;&nbsp;&nbsp;the information required with respect to the nomination of directors pursuant to Section&nbsp;1.13
of these <FONT STYLE="white-space:nowrap">by-laws;</FONT> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B)&nbsp;&nbsp;&nbsp;&nbsp;a representation and warranty that
the Nominating Stockholder will not engage in a &#147;solicitation&#148; within the meaning of Rule <FONT STYLE="white-space:nowrap">14a-1(l)</FONT> (without reference to the exception in
<FONT STYLE="white-space:nowrap">Section&nbsp;14a-1(l)(2)(iv))</FONT> (or any successor rules) with respect to the annual meeting, other than with respect to a Nominee or any nominee of the Board; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(C)&nbsp;&nbsp;&nbsp;&nbsp;a representation and warranty that the Nominating Stockholder will not use any proxy card other
than the Corporation&#146;s proxy card in soliciting stockholders in connection with the election of a Nominee at the annual meeting; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(D)&nbsp;&nbsp;&nbsp;&nbsp;if desired, a Supporting Statement; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(E)&nbsp;&nbsp;&nbsp;&nbsp;in the case of a nomination by a group, the designation by all group members of one group member
that is authorized to act on behalf of all group members with respect to matters relating to the nomination, including withdrawal of the nomination; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii)&nbsp;&nbsp;&nbsp;&nbsp;a representation and warranty that the Nominating Stockholder satisfies the eligibility
requirements set forth in Section&nbsp;1.14(c) and has provided evidence of ownership to the extent required by Section&nbsp;1.14(c)(i); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv)&nbsp;&nbsp;&nbsp;&nbsp;a representation and warranty that the stockholder acquired the securities of the Corporation in
the ordinary course of business and did not acquire, and is not holding, securities of the Corporation for the purpose or with the effect of changing control or influencing of the Corporation; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v)&nbsp;&nbsp;&nbsp;&nbsp;a representation and warranty that the Nominating Stockholder intends to continue to satisfy the
eligibility requirements described in Section&nbsp;1.14(c) through the date of the annual meeting and a statement regarding the Nominating Stockholder&#146;s intent with respect to continued ownership of the Minimum Number of shares for at least one
year following the annual meeting; provided, however, that any Eligible Holder that is a registered <FONT STYLE="white-space:nowrap">open-end</FONT> mutual fund under the Investment Company Act of 1940, and that seeks to replicate an index, will not
violate this requirement as a result of changes to its common stock holdings in response to changes in the index or weightings of the securities in the index; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-19- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(vi)&nbsp;&nbsp;&nbsp;&nbsp;An executed agreement, in a form deemed
satisfactory by the Board, pursuant to which the Nominating Stockholder (including each group member) agrees: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A)&nbsp;&nbsp;&nbsp;&nbsp;to comply with all applicable laws, rules and regulations in connection with the nomination,
solicitation and election; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B)&nbsp;&nbsp;&nbsp;&nbsp;to file any written solicitation or other written communication
with the Corporation&#146;s stockholders relating to one or more of the Corporation&#146;s directors or director nominees or any Nominee with the Securities and Exchange Commission, regardless of whether any such filing is required under rule or
regulation or whether any exemption from filing is available for such materials under any rule or regulation; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(C)&nbsp;&nbsp;&nbsp;&nbsp;to assume all liability stemming from an action, suit or proceeding concerning any actual or
alleged legal or regulatory violation arising out of any communication by the Nominating Stockholder or any of its Nominees with the Corporation, its stockholders or any other person in connection with the nomination or election of directors,
including, without limitation, the Proxy Access Notice; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(D)&nbsp;&nbsp;&nbsp;&nbsp;to indemnify and hold harmless
(jointly with all other group members, in the case of a group member) the Corporation and each of its directors, officers and employees individually against any liability, loss, damages, expenses or other costs (including attorneys&#146; fees)
incurred in connection with any threatened or pending action, suit or proceeding, whether legal, administrative or investigative, against the Corporation or any of its directors, officers or employees arising out of or relating to a failure or
alleged failure of the Nominating Stockholder or any of its Nominees to comply with, or any breach or alleged breach of, its or their obligations, agreements or representations under this Section&nbsp;1.14; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(E)&nbsp;&nbsp;&nbsp;&nbsp;in the event that any information included in the Proxy Access Notice, or any other communication
by the Nominating Stockholder (including with respect to any group member), with the Corporation, its stockholders or any other person in connection with the nomination or election ceases to be true and accurate in all material respects (or omits a
material fact necessary to make the statements made not misleading), or that the Nominating Stockholder (including any group member) has failed to continue to satisfy the eligibility requirements described in Section&nbsp;1.14(c), to promptly (and
in any event within 48 hours of discovering such misstatement, omission or failure) notify the Corporation and any other recipient of such communication of (A)&nbsp;the misstatement or omission in such previously provided information and of the
information that is required to correct the misstatement or omission or (B)&nbsp;such failure; and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-20- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(vii)&nbsp;&nbsp;&nbsp;&nbsp;An executed agreement, in a form deemed
satisfactory by the Board, by each Nominee: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A)&nbsp;&nbsp;&nbsp;&nbsp;to provide to the Corporation such other
information and certifications, including completion of the Corporation&#146;s director questionnaire, as it may reasonably request; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B)&nbsp;&nbsp;&nbsp;&nbsp;at the reasonable request of the Corporate Governance and Nominating Committee, to meet with the
Corporate Governance and Nominating Committee to discuss matters relating to the nomination of such Nominee to the Board, including the information provided by such Nominee to the Corporation in connection with his or her nomination and such
Nominee&#146;s eligibility to serve as a member of the Board; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(C)&nbsp;&nbsp;&nbsp;&nbsp;that such Nominee consents to
being named as a nominee in the Corporation&#146;s proxy statement and in any associated proxy card of the Corporation and agrees to serve if elected as a director of the Corporation. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(D)&nbsp;&nbsp;&nbsp;&nbsp;that such Nominee has read and agrees, if elected, to serve as a member of the Board, to adhere to
the Corporation&#146;s Corporate Governance Guidelines, Code of Business Conduct, Related Party Transaction Policy and any other Corporation policies and guidelines applicable to directors; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(E)&nbsp;&nbsp;&nbsp;&nbsp;that such Nominee is not and will not become a party to (i)&nbsp;any compensatory, payment or other
financial agreement, arrangement or understanding with any person or entity in connection with his or her nomination, service or action as a director of the Corporation that has not been disclosed to the Corporation, (ii)&nbsp;any agreement,
arrangement or understanding with any person or entity as to how such Nominee would vote or act on any issue or question as a director (a &#147;Voting Commitment&#148;) that has not been disclosed to the Corporation or (iii)&nbsp;any Voting
Commitment that could limit or interfere with such Nominee&#146;s ability to comply, if elected as a director of the Corporation, with its fiduciary duties under applicable law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The information and documents required by this Section&nbsp;1.14(d) to be provided by the Nominating Stockholder shall be: (i)&nbsp;provided
with respect to and executed by each group member, in the case of information applicable to group members; and (ii)&nbsp;provided with respect to the persons specified in Instruction 1 to Items 6(c) and (d)&nbsp;of Schedule 14N (or any successor
item) in the case of a Nominating Stockholder or group member that is an entity. The Proxy Access Notice shall be deemed submitted on the date on which all the information and documents referred to in this Section&nbsp;1.14(d) (other than such
information and documents contemplated to be provided after the date the Proxy Access Notice is provided) have been delivered to or, if sent by mail, received by the Secretary. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;<U>Exceptions</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding anything to the contrary contained in this Section&nbsp;1.14, the Corporation may
omit from its proxy statement any Nominee and any information concerning such Nominee (including a Nominating Stockholder&#146;s Supporting Statement) and no vote on such Nominee will occur (notwithstanding that proxies in respect of such vote may
have been received by the Corporation), and the Nominating Stockholder may not, after the last day on which a Proxy Access Notice would be timely, cure in any way any defect preventing the nomination of such Nominee, if: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-21- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A)&nbsp;&nbsp;&nbsp;&nbsp;the Corporation receives a notice pursuant to
Section&nbsp;1.13 of these <FONT STYLE="white-space:nowrap">by-laws</FONT> that a stockholder intends to nominate a candidate for director at the annual meeting, whether or not such notice is subsequently withdrawn or made the subject of a
settlement with the Corporation; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B)&nbsp;&nbsp;&nbsp;&nbsp;the Nominating Stockholder or the designated lead group
member, as applicable, or any qualified representative thereof, does not appear at the meeting of stockholders to present the nomination submitted pursuant to this Section&nbsp;1.14, the Nominating Stockholder withdraws its nomination or the Chair
of the annual meeting declares that such nomination was not made in accordance with the procedures prescribed by this Section&nbsp;1.14 and shall therefore be disregarded; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(C)&nbsp;&nbsp;&nbsp;&nbsp;the Board determines that such Nominee&#146;s nomination or election to the Board would result in
the Corporation violating or failing to be in compliance with the Corporation&#146;s <FONT STYLE="white-space:nowrap">by-laws</FONT> or certificate of incorporation or any applicable law, rule or regulation to which the Corporation is subject,
including any rules or regulations of the primary stock exchange on which the Corporation&#146;s common stock is traded; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(D)&nbsp;&nbsp;&nbsp;&nbsp;such Nominee was nominated for election to the Board pursuant to this Section&nbsp;1.14 at one of
the Corporation&#146;s two preceding annual meetings of stockholders and either withdrew or became ineligible or received a vote of less than 25% of the shares of common stock entitled to vote for such Nominee; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(E)&nbsp;&nbsp;&nbsp;&nbsp;such Nominee has been, within the past three years, an officer or director of a competitor, as
defined for purposes of Section&nbsp;8 of the Clayton Antitrust Act of 1914, as amended; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(F)&nbsp;&nbsp;&nbsp;&nbsp;the
Corporation is notified, or the Board determines, that the Nominating Stockholder or the Nominee has failed to continue to satisfy the eligibility requirements described in Section&nbsp;1.14(c), any of the representations and warranties made in the
Proxy Access Notice ceases to be true and accurate in all material respects (or omits a material fact necessary to make the statements made not misleading), such Nominee becomes unwilling or unable to serve on the Board or any material violation or
breach occurs of the obligations, agreements, representations or warranties of the Nominating Stockholder or such Nominee under this Section&nbsp;1.14; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-22- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii)&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding anything to the contrary
contained in this Section&nbsp;1.14, the Corporation may omit from its proxy statement, or may supplement or correct, any information, including all or any portion of the Supporting Statement or any other statement in support of a Nominee included
in the Proxy Access Notice, if the Board determines that: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A)&nbsp;&nbsp;&nbsp;&nbsp;such information is not true in all
material respects or omits a material statement necessary to make the statements made not misleading; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B)&nbsp;&nbsp;&nbsp;&nbsp;such information directly or indirectly impugns the character, integrity or personal reputation of,
or directly or indirectly makes charges concerning improper, illegal or immoral conduct or associations, without factual foundation, with respect to, any person; or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(C)&nbsp;&nbsp;&nbsp;&nbsp;the inclusion of such information in the proxy statement would otherwise violate the SEC proxy
rules or any other applicable law, rule or regulation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Corporation may solicit against, and include in the proxy statement its own
statement relating to, any Nominee. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">ARTICLE II </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>Board </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.1.&nbsp;&nbsp;&nbsp;&nbsp;<U>Power of Board and Qualification of Directors</U>. The business of the Corporation shall be
managed under the direction of the Board. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.2.&nbsp;&nbsp;&nbsp;&nbsp;<U>Number of Directors</U>. The number of directors
constituting the entire Board shall be the number, not less than three, fixed from time to time by a majority of the total number of directors which the Corporation would have, prior to any increase or decrease, if there were no vacancies, provided
that no decrease shall shorten the term of any incumbent director. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.3.&nbsp;&nbsp;&nbsp;&nbsp;<U>Election and Term of
Directors</U>. Directors elected at each annual or special meeting of stockholders shall hold office until the next annual meeting of stockholders, and until their successors are elected and qualified or until their earlier resignation or removal.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.4.&nbsp;&nbsp;&nbsp;&nbsp;<U>Quorum of Directors and Action by the Board</U>. Unless a greater proportion is required by
law or by the certificate of incorporation, <FONT STYLE="white-space:nowrap">one-half</FONT> of the entire Board shall constitute a quorum for the transaction of business or of any specified item of business. Except where otherwise provided by law
or in the certificate of incorporation or these <FONT STYLE="white-space:nowrap">by-laws,</FONT> the vote of a majority of the directors present at a meeting at the time of such vote, if a quorum is then present, shall be the act of the Board. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any action required or permitted to be taken by the Board may be taken without a meeting if all members of the Board consent in writing to the
adoption of a resolution authorizing the action. The resolution and the written consents by the members of the Board shall be filed with the minutes of the proceedings of the Board. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as otherwise provided by law, all corporate action to be taken by the Board shall be taken at a meeting of the Board or by unanimous
written consent. Any one or more members of the Board may participate in a meeting of the Board by means of a conference telephone or similar communications equipment allowing all persons participating in the meeting to hear each other at the same
time, and participation by such means shall constitute presence in person at such meeting. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-23- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.5.&nbsp;&nbsp;&nbsp;&nbsp;<U>Meetings of the Board</U>. An annual meeting of
the Board shall be held in each year as soon as practicable after the annual meeting of stockholders. Regular meetings of the Board shall be held at such times as may be fixed by the Board. Special meetings of the Board may be held at any time
whenever called by the Chair of the Board, if any, the Lead Independent Director, if any, the President or any two directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Meetings of
the Board shall be held at such places within or without the State of Delaware as may be fixed by the Board for annual and regular meetings and in the notice of meeting for special meetings. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No notice need be given of annual or regular meetings of the Board. Notice of each special meeting of the Board shall be given to each
director either by mail not later than noon, Eastern time, on the third day prior to the meeting, or by electronic transmission, telephonically or in person to the director not later than noon, Eastern time, on the day prior to the meeting. If
notice is sent by mail, it shall be sent by first class mail, charges prepaid. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notice of a meeting of the Board need not be given to any
director who submits a waiver of notice whether before or after the meeting, or who attends the meeting except when the directors attends a meeting for the express purpose of objecting, at the beginning of the meeting, to the transaction of any
business because the meeting is not lawfully called or convened. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A notice or waiver of notice need not specify the purpose of any meeting
of the Board. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Chair, if any, the Lead Independent Director, if any, or a majority of the directors present, whether or not a quorum
is present, may adjourn any meeting to another time and place. Notice of any adjournment of a meeting to another time or place shall be given in the manner described above to the directors who were not present at the time of the adjournment and,
unless such time and place are announced at the meeting, to the other directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.6.&nbsp;&nbsp;&nbsp;&nbsp;<U>Resignation</U>. Any director of the Corporation may resign at any time by giving written notice
to the Board, the Chair of the Board, if any, the Lead Independent Director, if any, President or the Secretary. Such resignation shall take effect at the time specified therein, and unless otherwise specified therein no acceptance of such
resignation shall be necessary to make it effective. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.7.&nbsp;&nbsp;&nbsp;&nbsp;<U>Removal of Directors</U>. Any director
or the entire Board may be removed, with or without cause, by the holders of a majority of the shares then entitled to vote at an election of directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.8.&nbsp;&nbsp;&nbsp;&nbsp;<U>Newly Created Directorships and Vacancies</U>. Newly created directorships resulting from an
increase in the number of directors and vacancies occurring in the Board for any reason may be filled by a majority of the directors then in office, although less than a quorum, or by the sole remaining director. A director elected to fill a vacancy
shall hold office until the next annual meeting of stockholders, and until his or her successor has been elected and qualified. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.9.&nbsp;&nbsp;&nbsp;&nbsp;<U>Compensation of Directors</U>. The Board shall have authority to fix the compensation of directors
for their service on the Board or any committee thereof. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-24- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">ARTICLE III </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>Committees </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.1.&nbsp;&nbsp;&nbsp;&nbsp;<U>Committees of Directors</U>. The Board, by resolution adopted by a majority of the entire Board,
may designate from among its members an Audit Committee, a Compensation Committee, a Nominating and Corporate Governance Committee and such other committees as it deems appropriate, each consisting of one or more directors, and each of which, to the
extent provided in the resolution, shall have all the powers and authority of the Board, except that no such committee shall have the power or authority as to the following matters: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">approving or adopting, or recommending to the stockholders, any action or matter (other than the election or
removal of directors) expressly required by Delaware law to be submitted to stockholders for approval; or </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">adopting, amending or repealing these <FONT STYLE="white-space:nowrap">by-laws.</FONT> </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board may designate one or more directors as alternate members of any such committee, who may replace any absent member or members at any
meeting of such committee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless the Board otherwise provides, each committee designated by the Board may adopt, amend and repeal rules
for the conduct of its business. In the absence of a provision by the Board or a provision in the rules of such committee to the contrary, a majority of the directors then serving on the committee shall constitute a quorum for the transaction of
business, the vote of a majority of the members present at a meeting at the time of such vote if a quorum is then present or the unanimous written consent of all members thereof shall be the act of such committee, any one or more members of such
committee may participate in a meeting of such committee by means of a conference telephone or similar communications equipment allowing all persons participating in the meeting to hear each other at the same time and participation by such means
shall constitute presence in person at such meeting, and in other respects each committee shall conduct its business in the same manner as the Board conducts its business pursuant to Article II of these
<FONT STYLE="white-space:nowrap">by-laws.</FONT> </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">ARTICLE IV </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>Officers </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.1.&nbsp;&nbsp;&nbsp;&nbsp;<U>Officers</U>. As soon as practicable after the annual meeting of stockholders in each year, the
Board shall elect or appoint a Chief Executive Officer, President, Chief Financial Officer, Secretary and Treasurer, and it may, if it so determines, elect or appoint from among its members a Chair of the Board and one or more Vice-Chair of the
Board. The Board may also elect or appoint one or more Vice-Presidents, Assistant Vice-Presidents, Assistant Secretaries and Assistant Treasurers and may give any of them such further designations or alternate titles as it considers desirable. Any
two or more offices may be held by the same person, except the offices of President and Secretary. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-25- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.2.&nbsp;&nbsp;&nbsp;&nbsp;<U>Lead Independent Director</U>. A majority of the
independent members of the Board may elect from among the independent members of the Board a Lead Independent Director, but the election of a Lead Independent Director shall not be required. The Lead Independent Director may be removed as a Lead
Independent Director by vote of a majority of the independent members of the Board. If a Lead Independent Director shall be elected, then the Lead Independent Director shall have such duties and authority as may be prescribed by the Board from time
to time. For purposes of this <FONT STYLE="white-space:nowrap">by-law,</FONT> &#147;independent&#148; has the meaning set forth in the rules of the primary stock exchange on which the Corporation&#146;s shares of common stock are traded at such
time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.3.&nbsp;&nbsp;&nbsp;&nbsp;<U>Term of Office; Resignation; Removal; Vacancies</U>. Unless otherwise provided in the
resolution of the Board electing any officer, each officer shall hold office until his or her successor is elected and qualified or until his or her earlier resignation or removal. Any officer may resign at any time upon written notice or electronic
transmission to the Board or to the President or the Secretary. Such resignation shall take effect at the time it is delivered unless the resignation specifies a later effective date or an effective date determined upon the happening of an event or
events. Unless otherwise specified therein, no acceptance of such resignation shall be necessary to make it effective. The Board may remove any officer with or without cause at any time. Any such removal shall be without prejudice to the contractual
rights of such officer, if any, with the Corporation, but the election of an officer shall not of itself create contractual rights. Any vacancy occurring in any office of the Corporation by death, resignation, removal or otherwise, may be filled by
the Board at any regular or special meeting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.4.&nbsp;&nbsp;&nbsp;&nbsp;<U>Powers and Duties</U>. The officers of the
Corporation shall have such authority and perform such duties in the management of the Corporation as may be prescribed by the Board and, to the extent not so prescribed, as generally pertain to their respective offices, subject to the control of
the Board. Securities of other corporations held by the Corporation may be voted by any officer designated by the Board and, in the absence of any such designation, by the President, any Vice-President, the Secretary or the Treasurer. The Board may
require any officer, agent or employee to give security for the faithful performance of his duties. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">ARTICLE V </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>Shares and Transfer of Shares </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.1.&nbsp;&nbsp;&nbsp;&nbsp;<U>Forms of Share Certificates</U>. The shares of the Corporation may be represented by certificates
or may be uncertificated shares. Except as otherwise expressly provided by law, the rights and obligations of the holders of uncertificated shares and the rights and obligations of the holders of certificates representing shares of the same class
and series shall be identical. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Shares represented by certificates shall be in such forms as the Board may prescribe, signed by any two
authorized officers of the Corporation (it being understood that each of the Chair of the Board, any Vice-Chair of the Board, the President, any Vice-President, the Secretary, any Assistant Secretary, the Treasurer, any Assistant Treasurer of the
Corporation, and the Chief Executive Officer of the Corporation shall be an authorized officer for such purpose), and may be sealed with the seal of the Corporation. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-26- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The signatures of the officers upon a certificate may be by electronic signature permitted
under the Delaware General Corporation Law. In case any officer who has signed or whose electronic signature has been placed upon a certificate shall have ceased to be such officer before such certificate is issued, it may be issued by the
Corporation with the same effect as if he or she were such officer at the date of issue. Each certificate representing shares shall state upon the face thereof (1)&nbsp;that the Corporation is formed under the laws of the State of Delaware;
(2)&nbsp;the name of the person or persons to whom issued; and (3)&nbsp;the number and class of shares, and the designation of the series, if any, which such certificate represents. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.2.&nbsp;&nbsp;&nbsp;&nbsp;<U>Transfers of Shares</U>. Shares represented by certificates of the Corporation shall be
transferable on the record of stockholders upon presentation to the Corporation or a transfer agent of a certificate or certificates representing the shares requested to be transferred, with proper endorsement on the certificate or on a separate
accompanying document, together with such evidence of the payment of transfer taxes and compliance with other provisions of law as the Corporation or its transfer agent may require. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.3.&nbsp;&nbsp;&nbsp;&nbsp;<U>Lost, Stolen or Destroyed Share Certificates</U>. The Corporation may issue a new certificate for
shares represented by certificates in place of any certificate theretofore issued by it, alleged to have been lost or destroyed, and the Corporation may require the owner of the lost or destroyed certificate, or such owner&#146;s legal
representative, to give the Corporation a bond sufficient to indemnify it against any claim that may be made against it on account of the alleged loss or destruction of any such certificate or the issuance of any such new certificate. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">ARTICLE VI </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>Other Matters
</U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.1.&nbsp;&nbsp;&nbsp;&nbsp;<U>Corporate Sea</U>l. The Board may adopt a corporate seal; alter such seal at pleasure,
and authorize it to be used by causing it or a reproduction of such seal to be affixed or impressed or reproduced in any other manner. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.2.&nbsp;&nbsp;&nbsp;&nbsp;<U>Fiscal Year</U>. The fiscal year of the Corporation shall be fixed by the Board. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.3.&nbsp;&nbsp;&nbsp;&nbsp;<U>Books to be Kep</U>t. The Corporation shall keep correct and complete books and records of
account, stock transfer books, minutes of the proceedings of its stockholders and Board and such other records as may be necessary or advisable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.4.&nbsp;&nbsp;&nbsp;&nbsp;<U>Interest of Directors and Officers in Transactions</U>. No contract or other transaction between
the Corporation and one or more of its directors or officers, or between the Corporation and any other corporation, firm, association or other entity or organization in which one or more of its directors or officers are directors or officers, or
have a substantial financial interest, shall be either void or voidable, irrespective of whether such interested director(s) or officer(s) are present at or participates in the meeting of the Board, or of a committee thereof, which approves such
contract or transaction and irrespective of whether his or their votes are counted for such purpose, if: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The material facts as to the director&#146;s or officer&#146;s relationship or interest and as to the contract
or transaction are disclosed or are known to the Board or the committee, and the board or committee in good faith authorizes the contract or transaction by the affirmative votes of a majority of the disinterested directors, even though the
disinterested directors be less than a quorum; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-27- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The material facts as to the director&#146;s or officer&#146;s relationship or interest and as to the contract
or transaction are disclosed or are known to the stockholders entitled to vote thereon, and the contract or transaction is specifically approved in good faith by vote of the stockholders; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The contract or transaction is fair as to the Corporation as of the time it is authorized, approved or
ratified, by the Board, a committee or the stockholders. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Interested directors or officers may be counted in determining
the presence of a quorum at a meeting of the Board or of a committee which authorizes the contract or transaction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.5.&nbsp;&nbsp;&nbsp;&nbsp;<U>Indemnification</U>. Except as provided in this <FONT STYLE="white-space:nowrap">by-law,</FONT>
the Corporation shall indemnify to the full extent permitted by Delaware law each person made or threatened to be made a party to any action or proceeding, whether civil or criminal, by reason of the fact that such person or such person&#146;s
testator or intestate is or was a director or officer of the Corporation, or serves or served at the request of the Corporation, any other corporation, partnership, joint venture, trust, employee benefit plan or other enterprise in any capacity,
against judgments, fines, penalties, amounts paid in settlement and reasonable expenses, including attorneys&#146; fees, incurred in connection with such action or proceeding, or any appeal therein, if such person acted in good faith and in a manner
the person reasonably believed to be in or not opposed to the best interests of the Corporation, and, with respect to any criminal action or proceeding, had no reasonable cause to believe the person&#146;s conduct was unlawful; provided, however,
that no such indemnification shall be required with respect to any settlement or other nonadjudicated disposition of any threatened or pending action or proceeding unless the Corporation has given its prior consent to such settlement or other
disposition. The termination of any action, suit or proceeding by judgment, order, settlement, conviction, or upon a plea of nolo contendere or its equivalent, shall not, of itself, create a presumption that the person did not act in good faith and
in a manner which the person reasonably believed to be in or not opposed to the best interests of the Corporation, and, with respect to any criminal action or proceeding, had reasonable cause to believe that the person&#146;s conduct was unlawful.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Corporation may advance or promptly reimburse upon request any person entitled to indemnification hereunder for all expenses,
including attorneys&#146; fees, reasonably incurred in defending any action or proceeding in advance of the final disposition thereof upon receipt of an undertaking by or on behalf of such person to repay such amount if such person is ultimately
found not to be entitled to indemnification or, where indemnification is granted, to the extent the expenses so advanced or reimbursed exceed the amount to which such person is entitled, provided, however, that such person shall cooperate in good
faith with any request by the Corporation that common counsel be utilized by the parties to an action or proceeding who are similarly situated unless to do so would be inappropriate due to actual or potential differing interests between or among
such parties. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-28- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Anything in these <FONT STYLE="white-space:nowrap">by-laws</FONT> to the contrary
notwithstanding, no elimination of this <FONT STYLE="white-space:nowrap">by-law,</FONT> and no amendment of this <FONT STYLE="white-space:nowrap">by-law</FONT> adversely affecting the right of any person to indemnification or advancement of expenses
hereunder shall be effective until the 60th day following notice to such person of such action, and no elimination of or amendment to this <FONT STYLE="white-space:nowrap">by-law</FONT> shall deprive any person of his or her rights hereunder arising
out of alleged or actual occurrences, acts or failures to act prior to such 60th day. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Corporation shall not, except by elimination or
amendment of this <FONT STYLE="white-space:nowrap">by-law</FONT> in a manner consistent with the preceding paragraph, take any corporate action or enter into any agreement which prohibits, or otherwise limits the rights of any person to,
indemnification in accordance with the provisions of this <FONT STYLE="white-space:nowrap">by-law.</FONT> The indemnification of any person provided by this <FONT STYLE="white-space:nowrap">by-law</FONT> shall continue after such person has ceased
to be a director, officer or employee of the Corporation and shall inure to the benefit of such person&#146;s heirs, executors, administrators and legal representatives. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Corporation is authorized to enter into agreements with any of its directors, officers or employees extending rights to indemnification
and advancement of expenses to such person to the fullest extent permitted by applicable law as it currently exists, but the failure to enter into any such agreement shall not affect or limit the rights of such person pursuant to this <FONT
STYLE="white-space:nowrap">by-law,</FONT> it being expressly recognized hereby that all directors, officers and employees of the Corporation, by serving as such after the adoption hereof, are acting in reliance hereon and that the Corporation is
estopped to contend otherwise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In case any provision in this <FONT STYLE="white-space:nowrap">by-law</FONT> shall be determined at any
time to be unenforceable in any respect, the other provisions shall not in any way be affected or impaired thereby, and the affected provision shall be given the fullest possible enforcement in the circumstances, it being the intention of the
Corporation to afford indemnification and advancement of expenses to its directors and officers, acting in such capacities or in the other capacities mentioned herein, to the fullest extent permitted by law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For purposes of this <FONT STYLE="white-space:nowrap">by-law,</FONT> the Corporation shall be deemed to have requested a person to serve an
employee benefit plan where the performance by such person of his or her duties to the Corporation also imposes duties on, or otherwise involves services by, such person to the plan or participants or beneficiaries of the plan, and excise taxes
assessed on a person with respect to an employee benefit plan pursuant to applicable law shall be considered indemnifiable expenses. For purposes of this <FONT STYLE="white-space:nowrap">by-law,</FONT> the term &#147;Corporation&#148; shall include
any legal successor to the Corporation, including any corporation which acquires all or substantially all of the assets of the Corporation in one or more transactions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.6.&nbsp;&nbsp;&nbsp;&nbsp;<U>Forum Selection</U>. Unless the Corporation consents in writing to the selection of an alternative
forum, (a)&nbsp;the Court of Chancery of the State of Delaware shall, to the fullest extent permitted by law (or, if the Court of Chancery of the State of Delaware does not have jurisdiction, then the Superior Court of Delaware shall, or if such
state courts in Delaware lack jurisdiction, the federal district court for the District of Delaware shall), be the sole and exclusive forum for (i)&nbsp;any derivative action or proceeding brought on behalf of the Corporation, (ii)&nbsp;any action
asserting a claim of breach of a fiduciary duty owed by any current or former director, officer, other employee or stockholder of the Corporation to the Corporation or the Corporation&#146;s stockholders, (iii)&nbsp;any action asserting a claim
arising pursuant to any provision of the Delaware General Corporation Law, the certificate of incorporation or these <FONT STYLE="white-space:nowrap">by-laws</FONT> (in each case, as they may be amended from time to time) or as to which the Delaware
General Corporation Law confers </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-29- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
jurisdiction on the Court of Chancery of the State of Delaware, or (iv)&nbsp;any action asserting a claim governed by the internal affairs doctrine; and (b)&nbsp;the federal district courts of
the United States shall be the exclusive forum for the resolution of any complaint asserting a cause of action arising under the Securities Act of 1933, as amended. Any person or entity purchasing or otherwise acquiring or holding any interest in
shares of capital stock of the Corporation shall be deemed to have notice of and consented to the provisions of this Section&nbsp;6.6. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.7.&nbsp;&nbsp;&nbsp;&nbsp;<U>Amendments</U>. These <FONT STYLE="white-space:nowrap">by-laws</FONT> may be amended or repealed,
and new <FONT STYLE="white-space:nowrap">by-laws</FONT> may be adopted, by the Board, but the stockholders entitled to vote may adopt additional <FONT STYLE="white-space:nowrap">by-laws</FONT> and may amend or repeal any <FONT
STYLE="white-space:nowrap">by-law</FONT> whether or not adopted by them by the affirmative vote of the holders of a majority in voting power of the outstanding shares of capital stock of the Corporation entitled to vote thereon. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-30- </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>5
<FILENAME>d193269dex41.htm
<DESCRIPTION>EX-4.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-4.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 4.1 </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Description of Common Stock </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following is a description of the general terms, provisions and rights of the common stock, par value $0.01 (&#147;<U>Common
Stock</U>&#148;), of CONMED Corporation, a Delaware corporation (the &#147;Company,&#148; &#147;we,&#148; &#147;us,&#148; and &#147;our&#148;), related provisions of the Company&#146;s certificate of incorporation (the &#147;<U>Certificate of
Incorporation</U>&#148;) and bylaws (the &#147;<U>Bylaws</U>&#148;) and applicable Delaware law. This description is qualified in its entirety by, and should be read in conjunction with, the Certificate of Incorporation and Bylaws, which have been
publicly filed with the Securities and Exchange Commission, and applicable Delaware law. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Authorized Shares </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have the authority to issue an aggregate of 100,000,000 shares of Common Stock. As of May&nbsp;21, 2020, there were 31,299,194 shares of our
Common Stock issued and 28,535,629 shares of our Common Stock outstanding. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Dividend Rights </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to the preferences, limitations and relative rights of holders of our preferred stock, the holders of Common Stock are entitled to
share ratably in dividends if, when and as declared by our board of directors out of funds legally available therefor. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Voting Rights </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to the preferences, limitations and relative rights of holders of our preferred stock, the holders of Common Stock are entitled to one
vote for each share held of record on all matters at all meetings of stockholders. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Liquidation Rights </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to the preferences, limitations and relative rights of holders of our preferred stock, the holders of Common Stock are entitled, in the
event of our liquidation, dissolution or <FONT STYLE="white-space:nowrap">winding-up,</FONT> to share ratably in the distribution of assets remaining after payment of debts and expenses. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Absence of Other Rights </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Common Stock has no sinking fund or redemption provisions or preemptive, conversion or exchange rights. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Anti-Takeover Effects of Our Certificate of Incorporation and Bylaws </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Certificate of Incorporation and Bylaws contain provisions that may delay, defer or discourage another party from acquiring control of us.
We expect that these provisions, some of which are summarized below, will discourage coercive takeover practices or inadequate takeover bids. These provisions are also designed to encourage persons seeking to acquire control of us to first negotiate
with the board of directors, which we believe may result in an improvement of the terms of any such acquisition in favor of our stockholders. However, they also give the board of directors the power to discourage acquisitions that some stockholders
may favor. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Special Meetings of Stockholders </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Bylaws provide that special meetings of stockholders may be called by the board of directors, the chair of the board of directors, if any,
the lead independent director of the board of directors, if any, or the president, or upon the request of stockholders holding at least 25% of the Company&#146;s outstanding stock entitled to vote, subject to certain procedural and informational
requirements for calling special meetings of stockholders set forth in the Bylaws. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Stockholder Action by Written Consent </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Certificate of Incorporation provides that stockholders can take action by written consent if stockholders holding not less than the
minimum number of votes required to authorize or take such action consent, subject to certain procedural safeguards set forth in the Certificate of Incorporation, including a requirement that the holders of at least 25% of the Company&#146;s
outstanding Common Stock (provided that such shares are determined to be Net Long Shares (as defined in the Bylaws) that have been held continuously for at least one year) request that the Board set a record date to determine the stockholders
entitled to act by written consent. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Advance Notice Requirements for Stockholder Proposals and Director Nominations </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Bylaws require compliance with advance notice procedures for stockholder proposals and director nominations to be brought before an annual
meeting of the stockholders. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Exclusive Forum </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Bylaws provide that unless the Company consents in writing to the selection of an alternate forum, (a)&nbsp;the Court of Chancery of the
State of Delaware will be the sole and exclusive forum for (i)&nbsp;any derivative action or proceeding brought on our behalf; (ii)&nbsp;any action asserting a breach of fiduciary duty owed by any of our directors, officers, employees, or
stockholders to the Company or our stockholders; (iii)&nbsp;any action asserting a claim arising pursuant to the Delaware General Corporation Law (the &#147;<U>DGCL</U>&#148;), our Certificate of Incorporation or our Bylaws; (iv)&nbsp;any action to
interpret, apply, enforce or determine the validity of our Certificate of Incorporation or our Bylaws; or (v)&nbsp;any action asserting a claim against us that is governed by the internal affairs doctrine (or, if the Court of Chancery does not have
jurisdiction, then the Superior Court of the State of Delaware, or if no state court in Delaware has jurisdiction, the federal district court for the District of Delaware); and (b)&nbsp;the federal district courts of the United States shall be the
exclusive forum for the resolution of any complaint asserting a cause of action arising under the Securities Act of 1933, as amended. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Amendment to
Certificate of Incorporation and Bylaws </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Delaware law provides generally that a majority vote of all the outstanding shares entitled to
vote thereon at a meeting of stockholders is required to approve amendments to a corporation&#146;s certificate of incorporation, unless a corporation&#146;s certificate of incorporation requires a greater percentage. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Delaware law provides generally that <FONT STYLE="white-space:nowrap">by-laws</FONT> may be amended, adopted or repealed by the vote of a
majority of the shares cast at a meeting of the Company&#146;s stockholders, unless the certificate of incorporation or <FONT STYLE="white-space:nowrap">by-laws</FONT> provide otherwise. Our Bylaws provide that they may be amended, altered or
repealed by a majority vote of the outstanding shares of the Company entitled to vote thereon. Additionally, if permitted under the corporation&#146;s certificate of incorporation, under Delaware law the board of directors may also amend, adopt or
repeal the Company&#146;s <FONT STYLE="white-space:nowrap">by-laws.</FONT> Our Certificate of Incorporation provides that the Bylaws may be amended, altered, or repealed by our board of directors without stockholder approval; provided, however, that
any <FONT STYLE="white-space:nowrap">by-law</FONT> adopted by the board of directors may be amended or repealed by our stockholders. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Delaware
Anti-Takeover Statute </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are subject to Section&nbsp;203 of the DGCL. Accordingly, we may not engage in a business combination, such
as a merger, consolidation, recapitalization, asset sale or disposition of stock, with any &#147;interested stockholder&#148; for a period of three years from the date that the interested stockholder first became an interested stockholder unless
certain conditions are met. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Indemnification and Limitations on Liability of Officers and Directors </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Certificate of Incorporation and Bylaws require the indemnification of directors and officers by the Company to the fullest extent
permitted by law, but our Bylaws provide that no indemnification is required with respect to any settlement or disposition of a proceeding unless the Company has given its prior consent to such settlement/disposition. Our Bylaws also permit us to
indemnify employees and to advance expenses to any person entitled to indemnification upon request. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;102(b)(7) of the DGCL
permits a corporation to provide in its certificate of incorporation that a director of the corporation shall not be personally liable to the corporation or its stockholders for monetary damages for breach of fiduciary duty as a director, except for
liability for (i)&nbsp;any breach of the director&#146;s duty of loyalty to the corporation or its stockholders, (ii)&nbsp;acts or omissions not in good faith or which involve intentional misconduct or a knowing violation of law, (iii)&nbsp;payments
of unlawful dividends or unlawful stock purchases or redemptions, or (iv)&nbsp;any transaction from which the director derived an improper personal benefit. Our Certificate of Incorporation contains a provision eliminating the personal liability of
directors for monetary damages to the fullest extent permitted by law. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Listing </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company&#146;s Common Stock is listed on the New York Stock Exchange under the trading symbol &#147;CNMD.&#148; </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Transfer Agent and Registrar </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
transfer agent and registrar for our Common Stock is Computershare Investor Services. </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>cnmd-20200521.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: 65.0.1 -->
<!-- Creation date: 5/22/2020 8:19:06 AM Eastern Time -->
<!-- Copyright (c) 2020 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2019-01-31"
  xmlns:cnmd="http://conmed.com/20200521"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://conmed.com/20200521"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd" namespace="http://xbrl.sec.gov/dei/2019-01-31" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cnmd-20200521_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cnmd-20200521_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://conmed.com//20200521/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>7
<FILENAME>cnmd-20200521_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: 65.0.1 -->
<!-- Creation date: 5/22/2020 8:19:06 AM Eastern Time -->
<!-- Copyright (c) 2020 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation, State or Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre-commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre-commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Title of 12(b) Security</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Title of 12(b) Security</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>8
<FILENAME>cnmd-20200521_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: 65.0.1 -->
<!-- Creation date: 5/22/2020 8:19:06 AM Eastern Time -->
<!-- Copyright (c) 2020 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://conmed.com//20200521/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="cnmd-20200521.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://conmed.com//20200521/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="20.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="21.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="24.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="25.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>d193269d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="cnmd-20200521.xsd" xlink:type="simple"/>
    <context id="duration_2020-05-21_to_2020-05-21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000816956</identifier>
        </entity>
        <period>
            <startDate>2020-05-21</startDate>
            <endDate>2020-05-21</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="duration_2020-05-21_to_2020-05-21"
      id="Hidden_dei_EntityCentralIndexKey_duration_2020-05-21_to_2020-05-21">0000816956</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="duration_2020-05-21_to_2020-05-21"
      id="Hidden_dei_AmendmentFlag_duration_2020-05-21_to_2020-05-21">false</dei:AmendmentFlag>
    <dei:AmendmentFlag contextRef="duration_2020-05-21_to_2020-05-21">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="duration_2020-05-21_to_2020-05-21">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2020-05-21_to_2020-05-21">2020-05-21</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="duration_2020-05-21_to_2020-05-21">CONMED CORPORATION</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2020-05-21_to_2020-05-21">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2020-05-21_to_2020-05-21">001-39218</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2020-05-21_to_2020-05-21">16-0977505</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2020-05-21_to_2020-05-21">525 French Road</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="duration_2020-05-21_to_2020-05-21">Utica</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2020-05-21_to_2020-05-21">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2020-05-21_to_2020-05-21">13502</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2020-05-21_to_2020-05-21">(315)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2020-05-21_to_2020-05-21">797-8375</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2020-05-21_to_2020-05-21">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2020-05-21_to_2020-05-21">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2020-05-21_to_2020-05-21">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2020-05-21_to_2020-05-21">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2020-05-21_to_2020-05-21">Common Stock, $0.01 par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2020-05-21_to_2020-05-21">CNMD</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2020-05-21_to_2020-05-21">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2020-05-21_to_2020-05-21">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MMWF\81AU8\K(XK%T-8943OTJDH\ Q:X831F:3LTXXFBD(3^ G/,6+V2?$9/
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M^L/O)FR]-@?SCXVO@ET+O^ZB^P)02P,$%     @ ]8&V4)E<G",0!@  G"<
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M.AQG0GS/]O:1I24RS^_Y"NM./&<?5I:P7<_/Y)Z,<B.[W?98??9/1VXCUZG
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M7Y1\-4DI?$[$/S0<7/+#/U!+ P04    " #U@;90NJ$YBM<!   R!@  #0
M 'AL+W-T>6QE<RYX;6S555N+U3 0_BLA/\"<=MD%I2WHPH*@LK#GP=>TG;:!
MW$RGQW9_O4G3V]$'\>"#OC0SWTR^^7*9-.MQDO#2 2 9E=1]3CM$^XZQONI
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M\$'B<UCQ',SI;G\*+TWRL&6=-XJ<[O9GJ,6@WLX%][]$\0-02P,$%     @
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M;',O+G)E;'-02P$"% ,4    " #U@;90)^B'#H(   "Q    $
M    @ 'I    9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( /6!ME#_\+G'
M[P   "L"   1              "  9D!  !D;V-0<F]P<R]C;W)E+GAM;%!+
M 0(4 Q0    ( /6!ME"97)PC$ 8  )PG   3              "  ;<"  !X
M;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ ]8&V4'W6E R= @  DPL
M !@              ( !^ @  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+
M 0(4 Q0    ( /6!ME"4'Y>04 (  .H%   4              "  <L+  !X
M;"]S:&%R9613=')I;F=S+GAM;%!+ 0(4 Q0    ( /6!ME"ZH3F*UP$  #(&
M   -              "  4T.  !X;"]S='EL97,N>&UL4$L! A0#%     @
M]8&V4!9M(W]# 0  / (   \              ( !3Q   'AL+W=O<FMB;V]K
M+GAM;%!+ 0(4 Q0    ( /6!ME#_P"8(O0   (4"   :              "
M ;\1  !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( /6!
MME +C]@#(0$  %<$   3              "  ;02  !;0V]N=&5N=%]4>7!E
<<UTN>&UL4$L%!@     *  H @ (   84      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>12
<FILENAME>0001193125-20-150104-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-20-150104-xbrl.zip
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MHE&;=+?D%K&/N%VHPYD/RI[GM:==J;H!9ML3W)[T)WU]M-XT]/,'4$L#!!0
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M#T,FQKA<KD5R^4:5938GN25PBZU@05 =A L$B3A.*L!NB=HL-]AX%NBJW5-
M?8L!]WC(Q?R+7H]+[@9EB;9EMH1S@0G,BZ@#<IX:$<6/\I#JUT:XJ9:S_%;J
MFP+>&\G,K# -1_2HF?E:@KR>S<HO)8H46H*YA"D\%%D'[D.J1)#K,HZ7J0-Q
M(8@JU<:]:1-9[)_II($!N%1JS63],;#HO(QAR#=H'XF]>,+!R-%N:CSB<HU.
M24.."F>EDBV2!0_SUGJ=M1T,IQ,>!J6O@^SGM;78R3. ]N.U%CI6+2+$(T7
M&0R&;Z9O(:U5?ZG32--9BBMW3@'N1+KF:[ZWV^442R_2GR2UA*R]=;0<K .K
M18B*U%@98NG:@#;0Z Z=);NE_#0]WW@+[9E5>8;<GMORIZK5".;'4'RZ[NM1
MG4@F!2"M0/,,>7-][YQ-5FR>[B[A^9+)N9Z@7R7>APN]0EJYHN*7?7,D6KU/
M6&P+#X;6OU-8($M$?')[+2T$<25(2A'=*6S0AN5685DOV1U7>LO\3HQD%X]_
M,X3>\Q]02P,$%     @ ]8&V4$2J6^2G!   X2H  !4   !C;FUD+3(P,C P
M-3(Q7W!R92YX;6S5FEV/XC84AN]7VO_@9F]:J2&$V9DN:)@58F8JU/D2L&W5
MFY5)#F#5L9%M!OCW/0YX1"#,PG1;Q7,!&<?OR>OS&"<YR>7G9<;),RC-I&@'
M<:T>$!")3)F8M(.Y#JE.& N(-E2DE$L![6 %.OA\]?[=Y0]A2*YO>P\D)%-C
M9KH518O%HI:.F="2SPV&U+5$9A$)0]>_._Q"?E\?KD4NSFOU6KR]5P&U,I)2
M RUR'C4:4:/>J)-/K;C9JE^0SCVYH=J $F3(,MB6RME*L<G4D!^3GT@NNI9"
M .>P(K=,4)$PRLG &?N9]$12(QW.2=_*-.F#!O4,:6T3E3/Q=\M^C*@&0MZ_
M(_B'Z1(Z;VT'=M";,2]'BM>DFJ#;^EGD1,&V9KDG6ISEDKC9;$;YWF)_S<IZ
MXP'BZ,_[NT$RA8R&F&I$D^P<"MVDYD6];>X\6N]T_35KZ3S2G4SRU!\Q+'*P
MA_TO=-U"VQ3&C? LKBUU&ES90ZZSJB2'/HR)_?[2[[T<,Y$B0P!VSN3<Z^>-
M.#)T*87,5I'M'5W+9)Z!,.Z[(](;89A9]<18JBP?0T#R=+:F"L;M(!%9&KIH
MULF'/@;Z>DH@LYKAQ-<LFW$(2+0UDIG"62-,WOL.&PH"6!H0*:0NC!W =Q_K
MU9KD9KK*I#!V][O,,6E(:A/Y'*7 \(AQTVZ$=B.LQQM('[#I:U?B@M 9::-H
M8HHIX':62.4:.1T!;P<EHNC[VUH/O8MY4)3W,*_+WV!UK+T#XJ+-;9@=E11"
M4Y6XL+A9(+G_.]CTB&948;PPF3+^,@G&2F:E*=L<3;YJ6*H45#MHU&NX#@1D
MIIA4V ]; C+7Z$G.K'O*[3X8@U*0WJW3<-!M;A775 UYS_\$7@?G;VKG\"VG
MDV.A[8BJ"VO'J(,4>P;)K3-#3.*QC(J:ZB(J^G2$&IX2>@)TC">#]!HOE$Y%
MM2.N/K,=PP[>F6?PUDMZ'R;,#E>8!YH=S:Y<6UUTY7X=N8]>DL,;!JEF4N4)
M'F">H2OG>'Y>=65Z(LAOA*HZUV_8=YC/O<1\RS@\S+,1J-.8;NNJ#G#;JZ-U
MX26M(5WV4DP&&[/U#>Q;T!T,4G6.!XT[J+]X";63IIAJO?G"^VJ(3P-:&J#J
M,$M-.Y"?? ;9Q<U'-90+\2:,VW)/(&Y;=@B;/B/,S_*/ZDG)9V;KC6_AN!?#
M$YA[OC=$SWRKPA1&]22UH?PO-CO]\K4\@B<T=UP[EKX5:^P*TU% 3Z%7U%27
M5]&G(^1;L<8^4N%/4RE.O)W8UU67U+Y71\NWZLP?Z-* Z,HLFXO-U;0^%MD!
M<76Y'3#LX/E6H!E(SA)FF)C<XZE:,6OP.')ERNIB*W/KF/E6;7E28*<?X!55
M7IBWCTK5XWA\_$+Y6H3J,GS-M6/I6RUF9TP]K>>@_CW1DCC><"WQ[NCZ5I09
M0#*W1N/&:,@,/_IR<U]777K[7ATMWRHO0T7MZUN#53:21Y\&=T35Y;1CU$'R
MK;;BIMO-,IE2,8%3G@66:ZN+K-SOAMQ'/VLH-QFH"<[#7Y5<F"FN^S,J3GP9
MZ4"(ZG)\U;;#^3^442ZCO=3<88-]9W.]QW[8-Q"QY1]02P,$%     @ ]8&V
M4+:J-W9V'@   FX!  X   !D,3DS,C8Y9#AK+FAT;>T]:W/B.+;?;]7]#RIF
M9R9=9<#F%4C2V4J3]$QF.X]*LCNS]\N4L470MK$9V0YA?_T]1[*-;<PK(0UT
MU%7=#5B6CG3>#TDG?W\>.N2)<I]Y[L>24=%+A+J69S/W\6,I#/KE=HG\_?1_
M_^=D$$!#:.SZ1S9E'TN#(!@=5:O//>Y4?&I5'KVG*CRHUG2C4]:-<MTH1<U#
MOQQ,1M1/WNF;?J_B\<=J_*3@)==SW7"8O#(>CRMB*'S-#G@5WZM"HS*THIQ9
M\7O/#G._9EX;U\5+1J?3J8JG<=.9ELD -5VO5_%QS_1IW-QRAW;2W/+<(;4K
MEC>$QM"\64L@?_99T?C0R*C^<?7EWAK0H5EFKA^8KI7T'@9\+BR=*CR-&S+?
M:]2,PP6 1RV2%Y[GM36@K0O3I']\NOLR;1X4MY\VK0;<=/V^QX=F &2#/37+
M>JU<:Z4Z*0-19#J*B619/^T4%>#@;-%4<ZN(3^T<<4:-6U7Y,&HZGT20T$N"
MXJEIX_\!"QQZ^AG ).WR/TZJ\CL\&-+ )-A-F?X5LJ>/I:[G!M0-R@] G"5B
MR6\?2P%]#JJB6U+%]ZI1SX20DYYG3_#CB<V>B!],'/JQ9#-_Y)@3Y %:.B4G
M[/D(WZ \^LQLF[KR,S2YE@Q &%#GK^+1G\"'?UZX .>D"P!PT[ET;?K\#SKY
MTPZY6.L_D6K+>K-<,_X,O-2W$G'-(<) V5%A%]&\GH,[VH=F2_L[U>%/VVAU
MFJV3:@;B93,X&U+7AK_!9\=\7 _RS*MK0]PW'9\N _:-!ZOF$,UIGW*0S-2'
M[RB:CGPA2& 8(J3:$4K$CR6?#4<.\H/X;< 1"I1<Y5A,59Y].WYL<HM[2'$K
M"\$W$*^G)]7L?*+99V8LOOM>R.57(1>.HI46=+/"2L>O44'6R5=FXP]]1CD1
M(-!"J=6]_$>6E/,O(]2%_8\ HYZ=? 6!Q8-S,Z"G4]CB-Z?/IK#:<]K&3Y)A
MDW&JF=5)5G.Z>M6T0*F"X#G-B)\^O%CVV7_ID:&/@N,QLX/!4;O29.[QT.2/
MS#W2B1D&7BG[&@Y6-AWVZ!Y9L 24X_-1_!1E?GE V>,@.-(K3>BWYW& H-SS
M@L ;XF_ZZ)GXGL-L\H,N_D1#&[K^8S1R.?!&1PA4]#5^>1243G_ZP6CIQR?5
MT6G!G%8'KKY9T&K%H"5#YR?RG.ZN@2_C:ZD7!';ZYI YDZ,'-J0^N:9C<N<-
M3?=8/!O+>?0\QSZ>F?9Q"KGMHG7,S:9T^L_KRX>+<W+_</9P<;]E6.XONO^\
MNWRXO+@G9]?GY.*/[J]GU[]<D.[-U=7E_?WES?6; 5A;"<#?37\ EG/@N1HY
MKW0KI*8W&QT)U(NHL34=Q*']X CY+D>>QAS:!%&O-Q/JY*([\7H*Z,)I/2\D
MV+?%^7,>NM+IYYN[*W+BCTPW!F$\8 $MPR\6!:4YYN8(N&2>=C[WK!"5<\HF
M6UTY"WMO1C4C+*<*J2OS20%2@8_O+JX?R-W%[<W=PY:Y]C;D?FBZ 0D\<D\M
MI EBU(G'B=$\L#]L&3JO3QX&% $+.0L8C'?Q; U,]Y&2,RL@\-CHU!O?%,@"
MA*(M@K#<T9'' W(0?Z<FV"+4#PA]@JX)%X^I_>%HOCT=<^RM,&@NI)VS+NL2
MZ59^+($K>F1#!T-X?6";DPE 1-W2Z94Y(35#(_A.GL<5;Q>10JVQ&BGD$+LF
MWO+NYQU]9#X&"H)K> *2X^;Z"NR1[LT=2(ZS!Z'SB[#W!JQ0:'C.\.O!Q;,)
M?(GS0 ;@"?S$](D_HA:Z"S9A+F&!3X"3@1_XA^^ Y#!48O8<2BSJ.*B=10Q1
M+XGO(].VX^\2-O%QQN5H3\UORW,<<^33(Y^.3* ;&C^(^CXJLL+G$^;L&LU,
MNR0GP>5_=F)OB%'JC1^/T1H/9%#(3GW,-:QG&V:?&HL>IEZ%?R(X>-QF9#[2
M<H]3\RN&#\'U/#*?/&;G2;24[?F)\H!9IA,1$RS'<80,6$ 8;&N,,E<!2,:_
M="V/@[80 N,^ /QWO= -^*3KV:]2!QB91%<[H"/N/>&PJ _.J6..034429-9
M=!4LZI0C5FB\%QCXS!P*SWH@>]8/^AGE>J=FM-_3<K["2Y$+_F ^7T8!)4NL
M\ M7WVB5]<[A85-O+O)>7BYFVKL@958+&1P(R8&VO!<,*"?_ 2/:MYDP\L4B
M; LP, U86L)]V$O.6!$)76\X9+Z_[35'@48D3WW7RWUY=U\A%\.1XTTHW^J*
M9\49N?8J'W*B!_Y%H_';6>QO[K&<V3:GOA_]]P4L=1#)S5J3?,9TQ@ F8MH[
MYK.\R0)TX>,-?_#&8%W]$QDE/VDM'P/8S+A"XM_P6S#NF,@-+[7]<''_[?&O
MRW)^FX'OU@, G/]C(V'(GAKUIE[[5O2PH@")($7_=<1A$=G(= A]IE88L"=T
M:X&CJ:^A!G-"%'CDOVP$RV/3MXN6?6->1NH] R-((NF@;C0_S)+'FO;>BX'Y
MXH&:N1UX;FR/GQYV#LOM^N%" V^+!#2-VOST0[MF'![[)* .'>$4B"OFD*8>
M\+O,-/GL=1QDM55/S0NA?0&E=P?4^DK JB7F"*09,"I:NCWOF?2HXXT)ZXN'
MHG!E*:6*3(>@'-)G#N*$^8"@@+HVM3$P[K-AZ 2F2[W0=R;$!^+U^Q,Q0O2"
MUX/9")H6@@.?I()?(73$B>E.XF=]SP$H\444Q<P7[QUD !5K9%,K,I&/1!^(
M\M*I3VD,[R_4I1SDTZ4+0X4R?']6J<E5^'"4XX2%"]M*$JZO#6;-P7H^M!5_
MF"&'5&1K36T>C2%,T-4<NU)1**KQXW&!?3M+.L=YOW=54>.B5G86^,2_<Q8
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M!B2_15RW"YZM+":(H?U% -N5L+[:J7W)>K^42?H+R!Z3PX4\Q&82BP/@$.J
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M#(5F:.],=GPE.TXH[Q5V^2L$L333;R3/9(6NMIA5\WA7-7@K6!U%J9?.CS-
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M-U;<8ZGPMCMX4RZ^<O'WE7:5M%$84QA3&%,84R[^MW'Q,6U_1YEK>7SD<5E
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M5KIJ,\V5$(P(6544:QK8K]%8GP<34G3_G'--FBM!&R6 .> 1@3]'R5K4<0C
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M,-(QOG%W&M=0^<9VZYE04,.IB_C^#2)<Q.QU4)V>DNA1R*OA0O^,%,5%0/7
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M(8(-$[/)I-):IVF89[.$8F1@C3W_"Y.A,'I'@$7E!+!G#F@5GBS6W!(]6>E
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M-<!5\Q7NXJ4%!-/[HTR%'_='"I(A]3*,E^%MCCC)T=O+X&KP?R F3W?,D(3
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M*M#@V2,%@)W%S!Y.@*^47'_L*(?5B,ID)*5):A1_TRY1$\963LOXW*-%!JV
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MF:;C>:6><*<9P0@MXV%4+:>U*=.R(J7$%53,C4 6I?D.I^\K0293Z CN <H
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MP'ML60R <.A.@M>(* 0PD2^\^5(61*G&#2IXM"?6# T%2PQ0OBDBF:/U)VQ
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M$6$NVM>$4[I=N>:"_Y"+D>/UWK@V7Z9O6/P@V7PNY1\_:"MT9%(B>WP$L[O
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MF1C?;UWU[;I8"%<)]SG3:YT"3[V87\]*N%W0L)_:'N:,8\GP#$A&"*1"BW%
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M.Z,[/C?!2/!Y<?P1#_G_9/HO4$L! A0#%     @ ]8&V4*;>-@,B P  N@H
M !$              ( !     &-N;60M,C R,# U,C$N>'-D4$L! A0#%
M  @ ]8&V4/;.!NM9!@  040  !4              ( !40,  &-N;60M,C R
M,# U,C%?;&%B+GAM;%!+ 0(4 Q0    ( /6!ME!$JEODIP0  .$J   5
M          "  =T)  !C;FUD+3(P,C P-3(Q7W!R92YX;6Q02P$"% ,4
M" #U@;90MJHW=G8>   ";@$ #@              @ &W#@  9#$Y,S(V.60X
M:RYH=&U02P$"% ,4    " #U@;90A6E9+CT9  "O<   $
M@ %9+0  9#$Y,S(V.61E>#(Q+FAT;5!+ 0(4 Q0    ( /6!ME">CL=\CA\
M !&4   0              "  <1&  !D,3DS,C8Y9&5X,S$N:'1M4$L! A0#
M%     @ ]8&V4,9'<62D;   4BH" !               ( !@&8  &0Q.3,R
M-CED97@S,BYH=&U02P$"% ,4    " #U@;90XH-D+.P-  #0-   $
M        @ %2TP  9#$Y,S(V.61E>#0Q+FAT;5!+!08     "  ( /D!  !L
%X0     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>13
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "d193269d8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "d193269d8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "cnmd-20200521_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cnmd-20200521_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "cnmd-20200521.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd"
     ]
    }
   },
   "elementCount": 23,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2019-01-31": 3,
    "total": 3
   },
   "keyCustom": 0,
   "keyStandard": 95,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "cnmd",
   "nsuri": "http://conmed.com/20200521",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d193269d8k.htm",
      "contextRef": "duration_2020-05-21_to_2020-05-21",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "role": "http://conmed.com//20200521/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d193269d8k.htm",
      "contextRef": "duration_2020-05-21_to_2020-05-21",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://conmed.com//20200521/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://conmed.com//20200521/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://conmed.com//20200521/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://conmed.com//20200521/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://conmed.com//20200521/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://conmed.com//20200521/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://conmed.com//20200521/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://conmed.com//20200521/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://conmed.com//20200521/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://conmed.com//20200521/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://conmed.com//20200521/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://conmed.com//20200521/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://conmed.com//20200521/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://conmed.com//20200521/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://conmed.com//20200521/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://conmed.com//20200521/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://conmed.com//20200521/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://conmed.com//20200521/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://conmed.com//20200521/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://conmed.com//20200521/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://conmed.com//20200521/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://conmed.com//20200521/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6623115600">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>May 21, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000816956<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May 21,  2020<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">CONMED CORPORATION<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-39218<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">16-0977505<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">525 French Road<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Utica<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NY<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">13502<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(315)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">797-8375<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.01 par value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CNMD<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>95</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d193269d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://conmed.com//20200521/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="d193269d8k.htm">d193269d8k.htm</File>
    <File>cnmd-20200521.xsd</File>
    <File>cnmd-20200521_lab.xml</File>
    <File>cnmd-20200521_pre.xml</File>
    <File>d193269dex21.htm</File>
    <File>d193269dex31.htm</File>
    <File>d193269dex32.htm</File>
    <File>d193269dex41.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2019-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
